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the areas of financial accounting and reporting. Statement 
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have been cleared by the Financial Accounting Standards 
Board as sources of established accounting principles in 
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ing principles that it establishes. AICPA members should 
consider the accounting principles in this Statement of Po­
sition if a different accounting treatment of a transaction or 
event is not specified by a pronouncement covered by Rule 
203 of the AICPA Code of Professional Conduct. In such 
circumstances, the accounting treatment specified by the 
Statement of Position should be used, or the member 
should be prepared to justify a conclusion that another 
treatment better presents the substance of the transaction 
in the circumstances.
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SUMMARY
This Statement of Position (SOP) provides guidance on ac­
counting and reporting by insurance enterprises for certain 
nontraditional long-duration contracts and for separate ac­
counts. This SOP requires, among other things, the following:
• Separate account presentation. The portion of sepa­
rate account assets representing contract holder 
funds should be measured at fair value and reported 
in the insurance enterprise’s financial statements as 
a summary total, with an equivalent summary total 
for related liabilities, if the separate account arrange­
ment meets all the criteria specified in paragraph 11 
of this SOP. If a separate account arrangement does 
not meet the criteria, assets representing contract 
holder funds under the arrangement should be ac­
counted for and recognized as general account as­
sets. Any related liability should be accounted for as 
a general account liability.
• Interest in separate accounts. Assets underlying an 
insurance enterprise’s proportionate interest in a 
separate account do not represent contract holder 
funds, and thus do not qualify for separate account 
reporting and valuation. If a separate account 
arrangement meets the criteria of paragraph 11 of 
this SOP and (a ) the terms of the contract allow the 
contract holder to invest in additional units in the 
separate account or (b) the insurance enterprise is 
marketing contracts that permit funds to be invested 
in the separate account, the assets underlying the in­
surance enterprise’s proportionate interest in the 
separate account should be accounted for in a man­
ner consistent with similar assets held by the general 
account that the insurance enterprise may be re­
quired to sell.
If the insurance enterprise’s proportionate interest 
in the separate account is less than 20 percent of the 
separate account and all of the underlying invest­
ments of the separate account meet the definition of
v
securities under Financial Accounting Standards 
Board (FASB) Statement of Financial Accounting 
Standards No. 115, Accounting for Certain Invest­
ments in Debt and Equity Securities, or paragraph 
46 of FASB Statement No. 60, Accounting and Re­
porting by Insurance Enterprises, as amended by 
FASB Statement No. 115, or cash and cash equiva­
lents, the insurance enterprise may report its por­
tion of the separate account value as an investment 
in equity securities classified as trading under FASB 
Statement No. 115.
Gains and losses on the transfer of assets from the 
general account to a separate account. Assets trans­
ferred from the general account to a separate ac­
count should be recognized at fair value to the extent 
of third-party contract holders’ proportionate inter­
est in the separate account if the separate account 
arrangement meets the criteria in paragraph 11 of 
this SOP. Any resulting gain related to the third- 
party contract holder’s proportionate interest should 
be recognized immediately in earnings of the general 
account of the insurance enterprise, provided that 
the risks and rewards of ownership have been trans­
ferred to contract holders using the fair value of the 
asset at the date of the contract holders assumption 
of risks and rewards. A guarantee of the asset’s value 
or minimum rate of return or a commitment to re­
purchase the asset would not transfer the risks of 
ownership, and no gain should be recognized. If the 
separate account arrangement does not meet the cri­
teria in paragraph 11 of this SOP, the transfer gener­
ally should have no financial reporting effect (that is, 
general account classification and carrying amounts 
should be retained). However, in certain situations, 
loss recognition may be appropriate.
Liability valuation. The basis for determining the 
balance that accrues to the contract holder for a 
long-duration insurance or investment contract that 
is subject to FASB Statement No. 97, Accounting 
and Reporting by Insurance Enterprises for Certain 
Long-Duration Contracts and for Realized Gains
vi
and Losses from  the Sale of Investments (para­
graphs 15 and 17(a)), is the accrued account bal­
ance. The accrued account balance equals:
1. Deposit(s) net of withdrawals;
2. Plus amounts credited pursuant to the contract;
3. Less fees and charges assessed;
4. Plus additional interest (for example, persistency 
bonus); and
5. Other adjustments (for example, appreciation or 
depreciation recognized in accordance with para­
graph 21 of this SOP to the extent not already 
credited and included in item 2).
For contracts that have features that may result in 
more than one potential account balance, the ac­
crued account balance should be based on the high­
est contractually determinable balance that will be 
available in cash or its equivalent at contractual ma­
turity or the reset date, without reduction for future 
fees and charges. The accrued account balance 
should not reflect any surrender adjustments (for ex­
ample, market value annuity adjustments, surrender 
charges, or credits). For contracts in which amounts 
credited as interest to the contract holder are reset 
periodically, the accrued balance should be based on 
the highest crediting rate guaranteed or declared 
through the reset date.
• Return based on a contractually referenced pool of 
assets or index. For a contract not accounted for 
under the provisions of FASB Statement No. 133, 
Accounting for Derivative Instruments and Hedging 
Activities, that provides a return based on the total re­
turn of a contractually referenced pool of assets either 
through crediting rates or termination adjustments, 
the accrued account balance should be based on the 
fair value of the referenced pool of assets (or applica­
ble index value) at the balance sheet date even if the 
related assets are not recognized at fair value.
• Determining the significance of mortality and mor­
bidity risk and classification of contracts that con-
vii
tain death or other insurance benefit features. To 
determine the accounting under FASB Statement No. 
97 for a contract that contains death or other insur­
ance benefit features, the insurance enterprise 
should first determine whether the contract is an in­
vestment or universal life-type contract. If the mor­
tality or morbidity risks are other than nominal and 
the fees assessed or insurance benefits are not fixed 
and guaranteed, the contract should be classified as 
a FASB Statement No. 97 universal-life type con­
tract. There is a rebuttable presumption that a con­
tract has significant mortality risk where the 
additional insurance benefit would vary significantly 
in response to capital markets volatility. The deter­
mination of significance should be made at contract 
inception, other than at transition, and should be 
based on a comparison of the present value of ex­
pected excess payments (that is, insurance benefit 
amounts and related incremental claim adjustment 
expenses in excess of the account balance) to be 
made under insurance benefit features with the pre­
sent value of all amounts expected to be assessed 
against the contract holder (revenue).
Accounting for contracts that contain death or other 
insurance benefit features. For contracts classified 
as insurance contracts that have amounts assessed 
against contract holders each period for the insur­
ance benefit feature that are assessed in a manner 
that is expected to result in profits in earlier years 
and subsequent losses from that insurance benefit 
function, a liability should be established in addition 
to the account balance to recognize the portion of 
such assessments that compensates the insurance 
enterprise for benefits to be provided in future peri­
ods in accordance with the guidance in paragraphs 
26 through 28 of this SOP.
Accounting for reinsurance and other similar con­
tracts. If a reinsurer assumes the insurance benefit 
feature, the reinsurer should assess the significance 
of mortality and morbidity risk within the reinsur­
ance contract according to the guidance in para-
viii
graphs 24 and 25 of this SOP, regardless of whether 
there is an account balance. The reinsurer should 
determine the classification of the reinsurance con­
tract as an investment contract or as an insurance 
contract at the inception of the reinsurance con­
tract. For reinsurance contracts, the mortality or 
morbidity risk could be deemed other than nominal 
even if the original issuer did not determine mortal­
ity or morbidity to be other than nominal. Similarly, 
the issuer of a contract that provides only an insur­
ance benefit feature that wraps a noninsurance con­
tract, for example, a guaranteed minimum death 
benefit related to a mutual fund balance, should eval­
uate its contract in the same manner. A reinsurer or 
issuer of the insurance benefit features of a contract 
should calculate a liability for the portion of premi­
ums collected each period that represents compen­
sation to the insurance enterprise for benefits that 
are assessed in a manner that is expected to result in 
current profits and future losses from the insurance 
benefit function. That liability should be calculated 
using the methodology described in paragraphs 26 
through 28 of this SOP.
• Accounting fo r  annuitization benefits. Contracts 
may provide for potential benefits in addition to the 
account balance that are payable only upon annuiti­
zation, such as annuity purchase guarantees, guaran­
teed minimum income benefit (GMIBs), and two-tier 
annuities. Insurance enterprises should determine 
whether such contract features should be accounted 
for under the provisions of FASB Statement No. 133. 
If the contract feature is not accounted for under the 
provisions of FASB Statement No. 133, an additional 
liability for the contract feature should be estab­
lished if the present value of expected annuitization 
payments at the expected annuitization date exceeds 
the expected account balance at the expected annu­
itization date in accordance with the guidance in 
paragraphs 31 through 35 of this SOP.
• Sales inducements to contract holders. Sales in­
ducements provided to the contract holder, whether
ix
for investment or universal life-type contracts, 
should be recognized as part of the liability for policy 
benefits over the period for which the contract must 
remain in force for the contract holder to qualify for 
the inducement or at the crediting date, if earlier, in 
accordance with paragraph 20 of this SOP. No adjust­
ments should be made to reduce the liability related 
to the sales inducements for anticipated surrender 
charges, persistency, or early withdrawal contractual 
features.
Sales inducements that are recognized as part of the 
liability under paragraph 36 of this SOP, that are ex­
plicitly identified in the contract at inception, and 
that meet the criteria specified in paragraph 37 of 
this SOP should be deferred and amortized using the 
same methodology and assumptions used to amor­
tize capitalized acquisition costs.
• Disclosures. The financial statements of an insur­
ance enterprise should disclose information related 
to the following:
1. Separate account assets and liabilities; the nature, 
extent, and timing of minimum guarantees related 
to variable contracts; and the amount of gains and 
losses recognized on assets transferred to separate 
accounts.
2. An insurance enterprise’s accounting policy for 
sales inducements, including the nature of the 
costs capitalized and the method of amortizing 
those costs; the amount of costs capitalized and 
amortized for each of the periods presented; and 
the unamortized balance as of each balance sheet 
date presented.
3. The nature of the liabilities and methods and as­
sumptions used in estimating any contract bene­
fits recognized in excess of the account balance 
pursuant to paragraphs 20 and 36 of this SOP.
This SOP is effective for financial statements for fiscal 
years beginning after December 15, 2003, with earlier 
adoption encouraged. This SOP should not be applied
x
retroactively to prior years’ financial statements. Initial ap­
plication of this SOP should be as of the beginning of an en­
tity’s fiscal year.
At the date of initial application of this SOP, an insurance 
enterprise will have to make various determinations, such 
as qualification for separate account treatment, FASB 
Statement No. 115 classification of securities in separate 
account arrangements not meeting the criteria in para­
graph 11 of this SOP, significance of mortality and morbid­
ity risk, adjustments to contract holder liabilities, and 
adjustments to estimated gross profits or margins,1 to de­
termine the cumulative effect of a change in accounting 
principle from adopting this SOP. Refer to paragraphs 41 
through 43 of this SOP for specific transition guidance.
1. The term estimated gross profits or margins relates to estimated gross profits as de­
fined in Financial Accounting Standards Board Statement of Financial Accounting 
Standards No. 97, Accounting and Reporting by Insurance Enterprises for Certain 
Long-Duration Contracts and for Realized Gains and Losses from the Sale of Invest­
ments, and estimated gross margins as defined in AICPA Statement of Position 95-1, 
Accounting fo r  Certain Insurance Activities of Mutual Life Insurance Enterprises, and 
will hereinafter be referred to as estimated gross profits.
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FOREWORD
The accounting guidance contained in this document has 
been cleared by the Financial Accounting Standards Board 
(FASB). The procedure for clearing accounting guidance in 
documents issued by the Accounting Standards Executive 
Committee (AcSEC) involves the FASB reviewing and dis­
cussing in public board meetings (1) a prospectus for a pro­
ject to develop a document, (2) a proposed exposure draft 
that has been approved by at least 10 of AcSEC’s 15 mem­
bers, and (3) a proposed final document that has been ap­
proved by at least 10 of AcSEC’s 15 members. The 
document is cleared if at least four of the seven FASB mem­
bers do not object to AcSEC undertaking the project,1 issu­
ing the proposed exposure draft or, after considering the 
input received by AcSEC as a result of the issuance of the 
exposure draft, issuing the final document.
The criteria applied by the FASB in its review of proposed 
projects and proposed documents include the following:
1. The proposal does not conflict with current or pro­
posed accounting requirements, unless it is a lim­
ited circumstance, usually in specialized industry 
accounting, and the proposal adequately justifies 
the departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed 
the costs of applying it.
In many situations, prior to clearance, the FASB will propose 
suggestions, many of which are included in the documents.
1. At the time the Accounting Standards Executive Committee (AcSEC) undertook this 
project, at least five of the seven Financial Accounting Standards Board members were 
required to not object to AcSEC undertaking this project.
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Accounting and Reporting by 
Insurance Enterprises for Certain 
Nontraditional Long-Duration 
Contracts and for Separate Accounts
Introduction and Background
Nontraditional Annuity and Life 
Insurance Contracts
1. At the time that Financial Accounting Standards Board 
(FASB) Statements of Financial Accounting Standards No. 60, 
Accounting and Reporting by Insurance Enterprises, as 
amended, and No. 97, Accounting and Reporting by Insur­
ance Enterprises fo r  Certain Long-Duration Contracts 
and fo r Realized Gains and Losses from the Sale of Invest­
ments, were issued, annuity and life insurance contracts 
were generally one of two basic designs: fixed or variable. 
Traditional fixed annuity and life insurance contracts, typically 
offered through an insurance enterprise’s general account,1 
provide for a fixed rate of interest over some specified period, 
with the insurance enterprise bearing the investment risk as­
sociated with the invested assets. Traditional variable annu­
ity and variable life insurance contracts, by contrast, offered 
through an insurance enterprise’s separate account, provide 
that all investment risks associated with the separate ac­
count assets are passed through to the contract holder, with 
no guarantees of return of principal, minimum crediting 
rates or, for annuity contracts, minimum death benefits.
2. More recently, annuity and life products with nontraditional 
terms have been developed. Some of those products may com­
bine fixed and variable features and are sold as general account or 
separate account products. The features of nontraditional con­
1. Terms defined in the glossary are set in boldface type the first time they appear in this 
Statement of Position (SOP).
1
tracts are many and complex, and may be offered in different 
combinations, such that there are numerous variations of the 
same basic products being sold in the marketplace. See examples 
of products in Appendix D of this Statement of Position (SOP).
3. A common feature in variable annuities is a minimum 
guaranteed death benefit (MGDB), such as a death benefit 
equal to the total deposits made by the contract holder less 
any withdrawals, referred to as “return of premium” or 
“basic” MGDB. Although the return of premium MGDB has 
become increasingly common in variable annuities, the 
trend has been for insurers to offer MGDBs with more ex­
tensive benefit guarantees, such as:
a. A death benefit equal to the total of deposits made to 
the contract less an adjustment for partial with­
drawals, accumulated at a specified interest rate, 
often referred to as “roll up.”
b. A death benefit equal to the account balance on a 
specified anniversary date adjusted for deposits less 
partial withdrawals since the specified anniversary 
date, often referred to as “reset.”
c. A death benefit equal to the highest account balance 
among prior specified anniversary dates adjusted for 
deposits less partial withdrawals since the specified 
anniversary date, often referred to as “ratchet.”
Another example of an insurance benefit feature is a no­
lapse guarantee, in which the company agrees to keep the 
insurance policy in force even when the account balance is 
not sufficient to pay the cost of insurance.
4. Some annuities may provide for potential benefits in addi­
tion to the account balance, payable only if annuitization is 
elected. For example, some deferred variable annuities now 
provide that, regardless of separate account performance, a 
guaranteed minimum amount is available to annuitize after 
a specified period, thereby providing a guaranteed minimum 
income benefit (GMIB) if the contract holder elects to annu­
itize. This benefit is in addition to the guaranteed minimum 
annuity interest rate traditionally offered. Another type of 
deferred annuity may provide multiple crediting rates 
throughout the life of the contract depending on whether the
2
contract holder elects to terminate or annuitize the con­
tract. An example is a contract that applies a lower rate to 
funds deposited if the contract holder elects to surrender the 
contract for cash, and a higher rate if the contract holder 
elects to annuitize, often referred to as a “two-tier” annuity.
5. Contracts also exist that potentially may be viewed as pro­
viding multiple account balances, for example, a contract 
that provides a return based on a contractually referenced 
pool of real estate assets owned by the insurance enterprise 
but also provides for minimum investment return guaran­
tees. Other contracts may exist that provide for the return 
of principal and interest if held until maturity or a specified 
“market adjusted value” if surrendered at an earlier date.
6. Sales inducements to contract holders may be offered with 
fixed and variable life insurance and annuity contracts. 
Those inducements may be offered in many forms, includ­
ing an immediate bonus, a persistency bonus credited to 
the contract holder’s account after a specified period, or an 
enhanced crediting rate, or “bonus interest” rate, in the 
initial period(s) of the contract.
7. FASB Statement No. 97 provides no explicit accounting 
guidance for the above examples of nontraditional contract 
features. This SOP addresses the insurance enterprise’s ac­
counting for certain contract features not covered by other 
authoritative accounting literature, including asset, liabil­
ity, revenue, and expense recognition. Embedded deriva­
tives contained in nontraditional contracts should be 
accounted for in accordance with FASB Statement No. 133, 
Accounting fo r Derivative Instruments and Hedging Ac­
tivities, and its related guidance.2
2. Refer to the Financial Accounting Standards Board’s (FASB’s) publication Accounting 
for Derivative Instruments and Hedging Activities. As of the date of publication of this 
SOP, the following insurance-specific FASB Derivative Implementation Issues were 
available: B7— Variable Annuity Products and Policyholder Ownership of the Assets, 
B8— Identification of the Host Contract in a Nontraditional Variable Annuity Contract, 
B9— Clearly and Closely Related Criteria for Market Adjusted Value Prepayment Op­
tions, B10— Equity-Indexed Life Insurance Contracts, B25— Deferred Variable Annuity 
Contracts with Payment Alternatives at the End of the Accumulation Period, B29— Eq­
uity-Indexed Annuity Contracts with Embedded Derivatives, B30— Application of 
Statement 97 and Statement 133 to Equity-Indexed Annuity Contracts, B34— Period 
Certain Plus Life-Contingent Variable Payout Annuity Contracts with a Guaranteed 
Minimum Level of Periodic Payments, and B36— Modified Coinsurance Arrangements 
and Debt Instruments That Incorporate Credit Risk Exposures That Are Unrelated or 
Only Partially Related to the Creditworthiness of the Obligor under Those Instruments.
3
8. In addition, this SOP addresses the insurance enterprise’s 
accounting for separate account assets and liabilities re­
lated to contracts for which all or a portion of the invest­
ment risk is borne by the insurer.
Applicability and Scope
9. This SOP is applicable to all entities to which FASB State­
ment No. 60, as amended, applies, hereinafter referred to 
as insurance enterprises.3
Conclusions
Separate Account Presentation
10. Separate account assets and liabilities should be included 
in the financial statements of the insurance enterprise 
that owns the assets and is contractually obligated to pay 
the liabilities.
11. The portion of separate account assets representing con­
tract holder funds should be measured at fair value and re­
ported in the insurance enterprise’s financial statements as 
a summary total, with an equivalent summary total re­
ported for related liabilities, if the separate account 
arrangement meets all of the following conditions:
а. The separate account is legally recognized. That is, 
the separate account is established, approved, and 
regulated under special rules such as state insurance 
laws, federal securities laws, or similar foreign laws.
b. The separate account assets supporting the con­
tract liabilities are legally insulated from the general 
account liabilities of the insurance enterprise (that 
is, the contract holder is not subject to insurer de­
fault risk to the extent of the assets held in the sep­
arate account).
3. FASB Statement of Financial Accounting Standards No. 60, Accounting and Reporting 
by Insurance Enterprises, as amended, applies to life insurance enterprises, property 
and liability insurance enterprises, title insurance enterprises, mortgage guaranty in­
surance enterprises, assessment enterprises, and fraternal benefit societies.
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c. The insurer must, as a result of contractual, statu­
tory, or regulatory requirements, invest the contract 
holder’s funds within the separate account as di­
rected by the contract holder in designated invest­
ment alternatives or in accordance with specific 
investment objectives or policies.
d. All investment performance, net of contract fees and 
assessments, must as a result of contractual, statu­
tory, or regulatory requirements be passed through 
to the individual contract holder. Contracts may 
specify conditions under which there may be a mini­
mum guarantee, but not a ceiling, as a ceiling would 
prohibit all investment performance from being 
passed through to the contract holder.
For the portion of separate account arrangements meeting 
these criteria, the related investment performance (includ­
ing interest, dividends, realized gains and losses, and 
changes in unrealized gains and losses) and the correspond­
ing amounts credited to the contract holder should be offset 
within the same statement of operations line item netting to 
zero. Contract fees and assessments should be reported in 
accordance with FASB Statement No. 97, paragraph 19. Any 
liabilities related to minimum guarantees and insurance ben­
efit liabilities under the contracts in excess of the fair value 
of separate account assets representing contract holder 
funds should be recognized as general account liabilities.
12. If a separate account arrangement does not meet the crite­
ria in paragraph 11 of this SOP, assets representing con­
tract holder funds under the arrangement should be 
accounted for (measured and presented) the same as other 
general account assets as prescribed in paragraphs 45 
through 51 of FASB Statement No. 60, as amended. Any re­
lated liability should be accounted for as a general account 
liability. Revenue and expenses related to such arrange­
ments should be recognized within the respective revenue 
and expense lines in the statement of operations. Arrange­
ments in which contract holders’ funds are maintained in 
separate accounts to fund fixed account options of variable 
contracts, market value adjusted contracts, guaranteed in­
vestment contracts, and indexed contracts are examples of
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separate account arrangements that would not meet the 
criteria in paragraph 11 because all of the investment per­
formance on these investments is not passed through to 
the contract holder.
Accounting for an Insurance Enterprise's 
Interest in a Separate Account
13. Assets underlying an insurance enterprise’s proportionate 
interest in a separate account (seed money or other invest­
ment as described in paragraph A12 of this SOP) do not 
represent contract holder funds, and thus do not qualify for 
separate account accounting and reporting. The insurance 
enterprise should “look through” the separate account4 for 
purposes of accounting for its interest therein, and account 
for and classify the assets of the separate account underly­
ing that interest based on their nature as if the assets of the 
separate account underlying the insurance enterprise’s 
proportionate interest were held directly by the general ac­
count rather than through the separate account structure.5
14. If a separate account arrangement meets the criteria in 
paragraph 11 of this SOP, and (a) the terms of the contract 
allow the contract holder to invest in additional units in 
the separate account or (b) the insurance enterprise is 
marketing contracts that permit funds to be invested in the 
separate account, the assets of the separate account under­
lying the insurance enterprise’s proportionate interest in 
the separate account should be accounted for in a manner 
consistent with the accounting for similar assets held by 
the general account that the insurance enterprise may be 
required to sell. For example:
a. For a debt or equity security with an unrealized loss, 
the loss should be accounted for as an other than 
temporary impairment consistent with the guidance 
of FASB Statement No. 115, Accounting for Certain 
Investments in Debt and Equity Securities, and rec­
ognized immediately in the statement of operations 
as a realized loss.
4. For purposes of this SOP, the term separate accounts includes separate accounts and 
subaccounts or investment divisions of separate accounts.
5. See the example in Appendix B.
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b. The guidance in FASB Statement No. 144, Account­
ing for the Impairment or Disposal of Long-Lived 
Assets, should be followed for both real estate that is 
held for sale and real estate that is not held for sale. 
For real estate that does not meet the FASB State­
ment No. 144 held for sale criteria, the impairment 
test should be performed solely using undiscounted 
cash flows assuming immediate disposition.
Transfers to Separate Accounts
15. Assets transferred from the general account to a separate 
account should be recognized at fair value to the extent of 
the third-party contract holders’ proportionate interests in 
the separate account if the separate account arrangement 
meets the criteria in paragraph 11 of this SOP. Any result­
ing gain related to the third-party contract holders’ propor­
tionate interest should be recognized immediately in 
earnings of the general account of the insurance enterprise 
provided that the risks and rewards of ownership have 
been transferred to contract holders using the fair value of 
the asset at the date of the contract holders’ assumption of 
risks and rewards.6 A guarantee of the asset’s value or min­
imum rate of return or a commitment to repurchase the 
asset would not transfer the risks of ownership, and no gain 
should be recognized. If the separate account arrangement 
does not meet the criteria in paragraph 11 of this SOP, the 
transfer generally should have no financial reporting effect 
(that is, general account classification and carrying 
amounts should be retained). Consistent with the guidance 
in footnote 9 of this SOP, the insurance enterprise should 
recognize an impairment loss on an asset transferred from 
the general account to a separate account not meeting the 
criteria in paragraph 11 of this SOP if the terms of the 
arrangement with the contract holder are such that the in­
surance enterprise will not be able to recover the asset’s 
carrying value. The insurance enterprise should recognize 
an impairment loss on its proportionate interest in a sepa­
rate account arrangement meeting the criteria in para-
6. If the asset transferred is real estate, no gain may be recognized if recognition is incon­
sistent with FASB Statement No. 66, Accounting for Sales of Real Estate.
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graph 11, in a situation where the current fair value of the 
insurance enterprise’s proportionate interest in the sepa­
rate account assets is less than its carrying amount.
16. If the transferred asset is subsequently sold by the separate 
account, any remaining unrecognized gain related to the 
insurance enterprise’s proportionate interest should be 
recognized immediately in the earnings of the general ac­
count of the insurance enterprise. If third-party contract 
holders’ proportionate interests in the separate account 
are subsequently increased, or the insurance enterprise 
otherwise reduces its proportionate interest in the separate 
account arrangement that meets the criteria in paragraph 
11 of this SOP, the reduction in the insurance enterprise’s 
proportionate interest may result in additional gain. If an 
insurance enterprise’s proportionate interest subsequently 
increases as a result of transactions executed at fair value 
(for example, at net asset value), the increase is considered 
a purchase from the contract holder and should be recog­
nized at fair value.
17. For example, the general account transfers to the separate 
account arrangement, as seed money, a debt security with 
a book value of $60 and a fair value of $100. No gain is rec­
ognized on the initial transfer to the separate account 
arrangement. Contract holders subsequently direct $100 
to the separate account arrangement, reducing the general 
account’s proportionate interest to 50 percent. Assuming 
the fair value of the debt security is still $100, the general 
account recognizes a gain of $20, as a result of the contract 
holder investment into the separate account arrangement. 
In subsequent years, if the insurance enterprise reduces its 
interest in the separate account arrangement through 
withdrawal of cash or additional investment by contract 
holders, additional gains would be recognized if the fair 
value of the security continues to exceed the general ac­
count’s basis in the security.
18. If the insurance enterprise’s proportionate interest in the sep­
arate account is less than 20 percent of the separate account 
and all of the underlying investments of the separate account 
meet the definition of securities under FASB Statement No. 
115 or paragraph 46 of FASB Statement No. 60, as amended
8
by FASB Statement No. 115, or cash and cash equivalents, the 
insurance enterprise may report its portion of the separate 
account value as an investment in equity securities under 
FASB Statement No. 115. This investment should be classi­
fied as trading and accounted for under the guidance in FASB 
Statement No. 115. The guidance in paragraphs 13 through
17 of this SOP should be applied when an insurance enter­
prise’s proportionate interest in the separate account repre­
sents 20 percent or greater of the separate account interest, 
or when the underlying investments are other than those 
that meet the definition of securities under FASB Statement 
No. 115 or paragraph 46 of FASB Statement No. 60, as 
amended by Statement No. 115, or cash and cash equivalents.
Valuation of Liabilities
19. Paragraphs 20 through 23 of this SOP provide guidance for 
determining the balance that accrues to the benefit of con­
tract holders under paragraphs 15 and 17(a) of FASB State­
ment No. 97. Paragraphs 24 through 30 of this SOP provide 
guidance for determining any additional liability for death 
or other insurance benefit features under paragraph 17(b) 
of FASB Statement No. 97. Paragraphs 31 through 35 of 
this SOP provide guidance for determining any additional 
liability for potential benefits available only upon annuiti­
zation. Paragraph 36 of this SOP provides guidance for de­
termining any additional liability for sales inducements.
20. The balance that accrues to the benefit of the contract 
holder for a long-duration insurance or investment con­
tract that is subject to FASB Statement No. 97 (paragraphs 
15 and 17(a)) is the accrued account balance. The accrued 
account balance7 equals:
a. Deposit(s) net of withdrawals;
b. Plus amounts credited pursuant to the contract;
c. Less fees and charges assessed;
d. Plus additional interest (for example, persistency 
bonus); and
7. The liability for the contract is the combination of amounts recorded in separate ac­
count liabilities and general account policyholder liabilities.
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e. Other adjustments (for example, appreciation or de­
preciation recognized in accordance with paragraph 
21 of this SOP to the extent not already credited and 
included in b above).
For purposes of item d above, additional interest is an 
amount that is required to be accrued under the liability 
valuation model that has not yet been credited to the con­
tract holder’s account. Additional interest, if any, should be 
accrued through the balance sheet date at the rate that 
would accrue to the balance available in cash, or its equiv­
alent,8 before reduction for future fees and charges, at the 
earlier of the date that the interest rate credited to the con­
tract is reset or contractual maturity. The reset date is the 
date at which the existing contractually declared invest­
ment return expires.
21. Some contracts, such as variable life and annuity and cer­
tain group pension participating and other experience­
rated contracts, provide for a return through periodic 
crediting rates, surrender adjustments, or termination ad­
justments based on the total return of a contractually ref­
erenced pool of assets owned by the insurance enterprise. 
Insurance enterprises should determine whether such con­
tracts will be accounted for under the provisions of FASB 
Statement No. 133.9 To the extent the contract is not ac­
counted for under the provisions of FASB Statement No. 
133, the amount of other adjustments described in para­
graph 20 of this SOP should be based on the fair value of 
the referenced pool of assets at the balance sheet date, 
even if the related assets are not recognized at fair value, to 
the extent not already credited to the accrued account bal­
ance and included in paragraph 20(b) of this SOP. Amounts 
determined for other adjustments are not reduced for fu­
ture fees and charges.10
8. For this purpose, an asset or contract is the equivalent of cash if it has a readily deter­
minable fair value and can be converted to cash without incurring significant transac­
tion costs.
9. Contracts that have been grandfathered under the provisions of paragraph 50 of FASB 
Statement No. 133 would need to follow the accounting guidance that is specified in 
paragraph 21 of this SOP.
10. A loss should be recognized in the statement of operations to the extent an asset re­
ported in the general account is designated as part of a contractually referenced pool 
of assets and on that designation date has an unrealized loss.
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22. For contracts that have features that may result in more 
than one potential account balance (for example, a con­
tract that provides a return based on a contractually refer­
enced pool of real estate assets owned by the insurance 
enterprise but also provides for minimum investment re­
turn guarantees), the accrued account balance should be 
based on the highest contractually determinable balance 
that will be available in cash or its equivalent at contrac­
tual maturity or the reset date, before reduction for future 
fees and charges. For contracts in which amounts credited 
as interest to the contract holder are reset periodically, the 
accrued balance should be based on the highest crediting 
rate guaranteed or declared through the reset date.
23. The accrued account balance should not reflect surrender 
adjustments (for example, market value annuity adjust­
ments,11 surrender charges, or credits). Any changes in the 
accrued account balance resulting from the application of 
the guidance in paragraphs 20 through 22 of this SOP should 
be reflected in net income in the period of the changes.
Contracts With Death or Other Insurance 
Benefit Features
Determining the Significance of Mortality and 
Morbidity Risk and Classification of Contracts That 
Contain Death or Other Insurance Benefit Features
24. To determine the accounting under FASB Statement No. 
60 or No. 97 for a contract that contains death or other 
insurance benefit features, the insurance enterprise 
should first determine whether the contract is an invest­
ment or insurance contract. Classification of a contract 
as an investment contract or as an insurance contract 
should be made at contract inception, and the classifica­
tion should not be reassessed during the accumulation 
phase of the contract. If the mortality and morbidity risk 
associated with insurance benefit features offered in a
11. For a description of a market value annuity and market value annuity adjustments 
refer to Appendix D, paragraph D1.
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contract is deemed to be nominal, that is, a risk of insignif­
icant12 amount or remote13 probability, the contract should 
be classified as an investment contract; otherwise, it should 
be considered an insurance contract. There is a rebuttable 
presumption that a contract has significant mortality risk 
where the additional insurance benefit would vary signifi­
cantly in response to capital markets volatility. If the mor­
tality or morbidity risk is other than nominal and the fees 
assessed or insurance benefits are not fixed and guaranteed, 
the contract should be classified as an FASB Statement No. 
97 universal life-type contract by the insurance enterprise. 
If the fees assessed on a contract and insurance benefits 
provided by the contract are fixed and guaranteed or if the 
contract is short duration, the contract should be classified 
under FASB Statement No. 60, as amended.
25. The determination of significance of mortality or morbidity risk 
should be based on a comparison of the present value of ex­
pected excess payments to be made under insurance benefit 
features (that is, insurance benefit amounts and related incre­
mental claim adjustment expenses in excess of the account bal­
ance, herein referred to as the “excess payments”) with the 
present value of all amounts expected to be assessed against the 
contract holder (revenue). For contracts that include invest­
ment margin14 in their estimated gross profits,15 the investment 
margin should be included with any other assessments for pur­
poses of determining significance. In performing the analysis, 
an insurance enterprise should consider both frequency and 
severity under a full range of scenarios that considers the 
volatility inherent in the assumptions, rather than making a 
best estimate using one set of assumptions. For example, if the 
annuity contract is a variable annuity contract, the insurance 
enterprise should consider a range of fund return scenarios. 
When considering a range of scenarios, the insurance enter­
prise should consider historical investment returns, the volatil­
ity of those returns, and expected future returns, as applicable.
12. The terms nominal and insignificant are as used in FASB Statement No. 97, Account­
ing and Reporting by Insurance Enterprises for Certain Long-Duration Contracts 
and for Realized Gains and Losses from the Sale of Investments, paragraph 40.
13. The term remote is as defined in FASB Statement No. 5, Accounting for Contingencies.
14. The term investment margin is as defined in FASB Statement No. 97, paragraph 23(c).
15. The term estimated gross profit is as defined in FASB Statement No. 97, paragraph 23.
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Accounting for a FASB Statement No. 97  
Universal Life-Type Contract With Death or 
Other Insurance Benefit Features
26. For a contract determined to meet the definition of an in­
surance contract as described in paragraphs 24 and 25, if 
the amounts assessed against the contract holder each pe­
riod for the insurance benefit feature are assessed in a 
manner that is expected to result in profits in earlier years 
and losses in subsequent years from the insurance benefit 
function, a liability should be established in addition to the 
account balance to recognize the portion of such assess­
ments that compensates the insurance enterprise for bene­
fits to be provided in future periods. Insurance coverage 
encompasses the concepts of amounts at risk and the rela­
tive probability of mortality and morbidity events. The 
amount of the additional liability should be determined 
based on the ratio (benefit ratio) of (a) the present value of 
total expected excess payments over the life of the con­
tract, divided by (b) the present value of total expected as­
sessments over the life of the contract. The benefit ratio 
may exceed 100 percent, resulting in a liability that ex­
ceeds cumulative assessments. Total expected assessments 
are the aggregate of all charges, including those for admin­
istration, mortality, expense, and surrender, regardless of 
how characterized. For contracts in which the assets are 
reported in the general account and that include invest­
ment margin in their estimated gross profits, the invest­
ment margin should be included with any other 
assessments for purposes of determining total expected as­
sessments. The insurance enterprise should calculate the 
present value of total expected excess payments and total 
assessments and investment margins, as applicable, based 
on expected experience. Expected experience should be 
based on a range of scenarios rather than a single set of 
best estimate assumptions. In calculating the additional li­
ability for the insurance benefit feature, assumptions used, 
such as the interest rate, discount rate, lapse rate, and 
mortality, should be consistent with assumptions used in 
estimating gross profits for purposes of amortizing capital­
ized acquisition costs. For contracts in which assessments 
are collected over a period significantly shorter than the
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period for which the contract is subject to mortality and 
morbidity risks, the assessment would be considered a 
front-end fee under FASB Statement No. 97 and accounted 
for under paragraph 20 of that Statement. The amounts 
recognized in income should be considered assessments 
for purposes of this paragraph.
27. The insurance enterprise should regularly evaluate esti­
mates used and adjust the additional liability balance, with 
a related charge or credit to benefit expense, if actual expe­
rience or other evidence suggests that earlier assumptions 
should be revised. In making such revised estimates, both 
the present value of total excess payments and the present 
value of total expected assessments and investment mar­
gins, should be calculated as of the balance sheet date 
using historical experience from the issue date to the bal­
ance sheet date and estimated experience thereafter.
28. The additional liability at the balance sheet date should be 
equal to:
a. The current benefit ratio multiplied by the cumula­
tive assessments16
b. Less the cumulative excess payments (including 
amounts reflected in claims payable liabilities)
c. Plus accreted interest
However, in no event should the additional liability balance 
be less than zero. The change in the additional liability 
should be recognized as a component of benefit expense in 
the statement of operations.
29. The estimated gross profits used for the amortization of de­
ferred acquisition costs should be adjusted to reflect the 
recognition of the liability in accordance with paragraph 28 
of this SOP.
16. The term cumulative assessments refers to actual cumulative assessments, including 
investment margins, if applicable, recorded from contract inception through the bal­
ance sheet date.
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Accounting for Reinsurance and Other 
Similar Contracts
30. If a reinsurer assumes the insurance benefit feature, the 
reinsurer should assess the significance of mortality and 
morbidity risk within the reinsurance contract according 
to the guidance in paragraphs 24 and 25 of this SOP, re­
gardless of whether there is an account balance. The rein­
surer should determine the classification of the 
reinsurance contract as an investment contract or as an in­
surance contract at the inception of the reinsurance con­
tract. For reinsurance contracts, the mortality or 
morbidity risk could be deemed other than nominal even if 
the original issuer did not determine mortality or morbid­
ity to be other than nominal. There is a rebuttable pre­
sumption that a contract has significant mortality risk 
where the additional insurance benefit would vary signifi­
cantly in response to capital markets volatility. Similarly, 
the issuer of a contract that provides only an insurance 
benefit feature that wraps17 a noninsurance contract, for 
example, a guaranteed minimum death benefit related to a 
mutual fund balance, should evaluate its contract in the 
same manner. A reinsurer or issuer of the insurance bene­
fit features of a contract should calculate a liability for the 
portion of premiums collected each period that represents 
compensation to the insurance enterprise for benefits that 
are assessed in a manner that is expected to result in cur­
rent profits and future losses from the insurance benefit 
function. That liability should be calculated using the 
methodology described in paragraphs 26 through 28 of this 
SOP. For example, a reinsurance contract that assumes 
only the risk related to the MGDB feature for a fee that 
varies with the account balance rather than with the insur­
ance coverage provided would be a FASB Statement No. 97 
universal life-type contract and the contract should be ac­
counted for in accordance with paragraphs 26 through 28 
of this SOP.
17. The term wrap refers to the practice of adding an insurance benefit feature to a sepa­
rate noninsurance contract generally from a different issuer.
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Accounting for Contracts That Provide 
Annuitization Benefits
31. Contracts may provide for potential benefits in addition to 
the account balance that are payable only upon annuitiza­
tion, such as annuity purchase guarantees, GMIBs and two- 
tier annuities. Insurance enterprises should determine 
whether such contract features should be accounted for 
under the provisions of FASB Statement No. 133.18 If the 
contract feature is not accounted for under the provisions 
of FASB Statement No. 133, an additional liability for the 
contract feature should be established if the present value 
of expected annuitization payments at the expected annu­
itization date exceeds the expected account balance at the 
expected annuitization date. The amount of the additional 
liability should be determined based on the ratio (benefit 
ratio) of (a) the present value of expected annuitization 
payments to be made and related incremental claim ad­
justment expenses, discounted at estimated investment 
yields expected to be earned during the annuitization 
phase of the contract, minus the expected accrued account 
balance at the expected annuitization date (the “excess 
payments”), divided by (b) the present value of total ex­
pected assessments during the accumulation phase of the 
contract. Total expected assessments are the aggregate of 
all charges, including those for administration, mortality, 
expense, and surrender, regardless of how characterized. 
For contracts whose assets are reported in the general ac­
count and that include investment margin in their esti­
mated gross profits, the investment margin should be 
included with any other assessments for purposes of deter­
mining total expected assessments. The insurance enter­
prise should calculate the present value of total expected 
excess payments and total assessments and investment 
margins, as applicable, based on expected experience. Ex­
pected experience should be based on a range of scenarios 
that considers the volatility inherent in the assumptions 
rather than a single set of best estimate assumptions. In
18. Refer to FASB Derivative Implementation Issue: B25— Deferred Variable Annuity 
Contracts with Payment Alternatives at the End of the Accumulation Period, Ques­
tions 1 and 2, for discussion of these products.
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calculating the additional liability for the additional benefit 
feature, assumptions used, such as the interest rate, discount 
rate, lapse rate, and mortality, should be consistent with as­
sumptions used in estimating gross profits for purposes of 
amortizing capitalized acquisition costs. When determining 
expected excess payments, the expected annuitization rate 
is one of the assumptions that needs to be estimated.
32. The insurance enterprise should regularly evaluate esti­
mates used and adjust the additional liability balance, with 
a related charge or credit to benefit expense, if actual expe­
rience or other evidence suggests that earlier assumptions 
should be revised. In making such revised estimates, both 
the present value of total excess payments and the present 
value of total expected assessments or investment margins 
should be calculated as of the balance sheet date using his­
torical experience from the issue date to the balance sheet 
date and estimated experience thereafter.
33. The additional liability at the balance sheet date should be 
equal to:
а. The current benefit ratio multiplied by the cumula­
tive assessments
b. Plus accreted interest
c. Less, at time of annuitization, the cumulative excess 
payments determined at annuitization
However, in no event should the additional liability balance 
be less than zero. The change in the additional liability 
should be recognized as a component of benefit expense in 
the statement of operations. “Cumulative excess payments 
determined at annuitization” represent the amount that 
should be deducted at the actual date of annuitization. 
That amount should be calculated as the present value of 
expected annuity payments and related claim adjustment 
expenses discounted at expected investment yields minus 
the accrued account balance at the actual annuitization 
date. On the date of annuitization, the additional liability 
related to the cumulative excess benefits will be zero and 
the amount deducted will be used in the calculation of the 
liability for the payout annuity.
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34. The estimated gross profits used for the amortization of de­
ferred acquisition costs should be adjusted to reflect the 
recognition of the liability determined in accordance with 
paragraph 32 of this SOP. Capitalized acquisition costs 
should continue to be amortized over the present value of 
estimated gross profits (as adjusted above) over the ex­
pected life of the book of contracts. For purposes of amorti­
zation of deferred acquisition costs, the life of the book of 
contracts excludes the annuitization phase.
35. A reinsurer may agree to reinsure all or a portion of the ad­
ditional benefits described in paragraph 31 of this SOP. 
Both the ceding company and the reinsurer should deter­
mine whether such a reinsurance contract should be ac­
counted for under the provisions of FASB Statement No. 
133. For example, unlike many of the direct contracts that 
contain GMIB benefits, contracts to reinsure GMIB benefits 
often meet the definition of a derivative under FASB State­
ment No. 133. If the reinsurance contract should not be ac­
counted for under the provisions of FASB Statement No. 
133, the guidance in paragraphs 31 through 34 of this SOP 
should be followed.
Sales Inducements to Contract Holders
36. Sales inducements provided to the contract holder, 
whether for investment or universal life-type contracts, 
should be recognized as part of the liability for policy ben­
efits over the period in which the contract must remain in 
force for the contract holder to qualify for the inducement 
or at the crediting date, if earlier, in accordance with para­
graph 20 of this SOP. No adjustments should be made to re­
duce the liability related to the sales inducements for 
anticipated surrender charges, persistency, or early with­
drawal contractual features.
37. Sales inducements that (a) are recognized as part of the li­
ability under paragraph 36 of this SOP, (b) are explicitly 
identified in the contract at inception, and (c) meet the cri­
teria in the following sentence should be deferred and 
amortized using the same methodology and assumptions 
used to amortize capitalized acquisition costs. The insur­
ance enterprise should demonstrate that such amounts are
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(a) incremental to amounts the enterprise credits on simi­
lar contracts without sales inducements and (b) higher 
than the contract’s expected ongoing crediting rates for pe­
riods after the inducement, as applicable; that is, the credit­
ing rate excluding the inducement should be consistent 
with assumptions used in estimated gross profits, contract 
illustrations, and interest-crediting strategies. Due to the 
nature of day-one and persistency bonuses, the criteria in 
the preceding sentence are generally met. The deferred 
amount should be recognized on the statement of financial 
position as an asset, and amortization should be recognized 
as a component of benefit expense. The annuitization phase 
is viewed as a separate contract under FASB Statement No. 
97, and should not be combined with the accumulation 
phase for amortization of deferred sales inducements.
Disclosures
38. The following information should be disclosed in the finan­
cial statements of the insurance enterprise:
а. The general nature of the contracts reported in sepa­
rate accounts, including the extent and terms of 
minimum guarantees.
b. The basis of presentation for separate account assets 
and liabilities and related separate account activity.
c. A description of the liability valuation methods and 
assumptions used in estimating the liabilities for ad­
ditional insurance benefits and minimum guarantees.
d. Disclosures should include the following amounts re­
lated to minimum guarantees:
(1) The separate account liability balances subject 
to various types of benefits (for example, guaran­
teed minimum death benefit, guaranteed mini­
mum income benefit, guaranteed minimum 
accumulation benefit). Disclosures within these 
categories of benefits for the types of guarantees 
provided may also be appropriate (for example, 
return of net deposits, return of net deposits ac­
crued at a stated rate, return of highest anniver­
sary value).
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(2) The amount of liability reported for additional 
insurance benefits, annuitization benefits and 
other minimum guarantees, by type of benefit, 
for the most recent balance sheet date and the in­
curred and paid amounts for all periods presented.
(3) For contracts for which an additional liability is 
disclosed in paragraph 38(d)(2), net amount at 
risk and weighted average attained age of con­
tract holders.
e. The aggregate fair value of assets, by major invest­
ment asset category, supporting separate accounts 
with additional insurance benefits and minimum in­
vestment return guarantees as of each date for which 
a statement of financial position is presented.
f . The amount of gains and losses recognized on assets 
transferred to separate accounts for the periods presented.
39. An insurance enterprise should disclose its accounting pol­
icy for sales inducements, including the nature of the costs 
deferred and the method of amortizing those costs. The 
amount of costs deferred and amortized for each of the pe­
riods presented and the unamortized balance as of each 
balance sheet date also should be disclosed.
Effective Date and Transition
40. The provisions of this SOP are effective for financial state­
ments for fiscal years beginning after December 15, 2003, 
with earlier adoption encouraged. Restatement of previ­
ously issued annual financial statements or reclassification 
between separate account and general account balances is 
not permitted. Initial application of this SOP should be as 
of the beginning of an entity’s fiscal year (that is, if the SOP 
is adopted prior to the effective date and during an interim 
period, all prior interim periods should be restated). Dis­
closure of the pro forma effects of retroactive application 
(discussed in paragraph 21 of Accounting Principles Board 
(APB) Opinion No. 20, Accounting Changes) or the pro 
forma effect on the year of adoption is not required.
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41. At the date of initial application:
a. For assets that no longer qualify for separate account 
treatment:
(1) Debt or equity securities previously classified as 
separate account assets but valued in accordance 
with FASB Statement No. 115 should maintain 
their designations as held-to-maturity, available- 
for-sale, or trading upon reclassification to the gen­
eral account.
(2) The provisions of FASB Statement No. 115 should 
be adopted for any debt or equity securities previ­
ously recognized at fair value in accordance with 
paragraph 54 of FASB Statement No. 60, as 
amended. Any adjustment for FASB Statement No. 
115 designation resulting from initial adoption 
should be reported in a manner similar to the cumu­
lative effect of a change in accounting principle in 
accordance with the provisions of APB Opinion No.
20 and paragraph 25 of FASB Statement No. 115:
(a) If designated as held-to-maturity, the adjust­
ment should be reported through income.
(b) If designated as available-for-sale, the adjust­
ment should be reported in income, with a 
corresponding cumulative effect adjustment 
for the unrealized holding gains and losses re­
ported in other comprehensive income.
(c) If designated as trading, there should be no 
adjustment.
(3) Any revaluation adjustments related to assets 
that are not subject to FASB Statement No. 115 
should be reported in a manner similar to the cu­
mulative effect of a change in accounting princi­
ple in accordance with the provisions of APB 
Opinion No. 20.
b. The guidance in paragraph 41(a) of this SOP should 
be applied in accounting for an insurance enterprise’s 
proportionate interest in the separate account assets 
regardless of whether the interest was previously re­
ported in the separate account or the general account.
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If the insurance enterprise considered its portion of 
separate account units to be equity securities under 
FASB Statement No. 115, the guidance in paragraph 
41(a)(1) or (3) should be applied as appropriate.
c. To the extent a debt or equity security subject to 
FASB Statement No. 115 and previously classified as 
available-for-sale is part of a contractually referenced 
pool of assets in which total return will be accrued to 
the account balance (in accordance with paragraph
21 of this SOP), and a transition adjustment for the li­
ability valuation is reported in accordance with 41(e), 
that security may be reclassified to trading with the 
revaluation adjustment recognized as a cumulative ef­
fect similar to the liability transition adjustment.
d. For contracts that are in force on the date of initial 
application of this SOP, the determination of signifi­
cance of mortality and morbidity risk resulting from 
insurance benefit features, in accordance with para­
graphs 24 through 25 of this SOP, should be per­
formed as of the date of initial application of this 
SOP using both actual results from inception of the 
contract through the date of initial application and 
expected future results thereafter.
e. Any adjustment in contract holder liabilities from 
adopting this SOP should be reported in a manner 
similar to the cumulative effect of a change in ac­
counting principle in accordance with the provisions 
of APB Opinion No. 20, through income or, for 
amounts previously accrued under Emerging Issues 
Task Force (EITF) Topic No. D-41, Adjustments in 
Assets and Liabilities for Holding Gains and Losses 
as Related to the Implementation of FASB Statement 
No. 115, accumulated other comprehensive income.
f . If the adoption of this SOP results in changes in esti­
mated gross profits, any adjustments to unamortized 
deferred acquisition costs or present value of future 
profits19 should be reported in a manner similar to
19. Adjustments are as discussed in Emerging Issues Task Force (EITF) Issue No. 92-9, 
Accounting for the Present Value of Future Profits Resulting from the Acquisition of a 
Life Insurance Company.
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the cumulative effect of a change in accounting princi­
ple in accordance with the provisions of APB Opinion 
No. 20, through income or, for amounts previously ac­
crued under EITF Topic No. D-41, accumulated other 
comprehensive income.
42. This SOP should be applied prospectively with respect to the 
deferral of sales inducements meeting the criteria in paragraph 
37 of this SOP. Sales inducements deferred subsequent to the 
initial application of this SOP on policies in force at that date 
should be accounted for in accordance with paragraph 37 of 
this SOP. Costs recognized for sales inducements prior to ini­
tial application of this SOP other than for those referred to in 
paragraph 43 of this SOP, whether capitalized or not, should 
not be adjusted to the amounts that would have been deferred 
had this SOP been in effect when those costs were incurred. 
Costs capitalized for sales inducements prior to initial applica­
tion of this SOP that were previously reported with unamor­
tized deferred acquisition costs should be reported separately.
43. Insurance enterprises that were previously amortizing sales in­
ducements using the same methodology and assumptions used 
for amortizing deferred acquisition costs (the approach re­
quired by the guidance in this SOP) should continue using that 
approach and should consider the entire life of the contracts. 
Any cumulative adjustment to unamortized sales inducements 
resulting from changes in estimated gross profits, made as a re­
sult of the initial adoption of this SOP, should be reported in a 
manner similar to the cumulative effect of a change in account­
ing principle in accordance with the provisions of APB Opinion 
No. 20, through net income or, for amounts previously accrued 
under EITF Topic No. D-41, accumulated other comprehensive 
income. However, if an insurance enterprise had been amortiz­
ing sales inducements using a methodology or assumptions 
other than those used for amortizing deferred acquisition costs, 
the amortization of deferred sales inducements after implemen­
tation of this SOP should consider only estimated gross profits 
or interest, as applicable, depending on the amortization 
methodology, from the date of initial application forward.
The provisions of this Statement need not 
be applied to immaterial items.
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APPENDIX A
Basis for Conclusions
A.1 This section discusses considerations that were deemed 
significant by the Accounting Standards Executive Com­
mittee (AcSEC) in reaching the conclusions in this State­
ment of Position (SOP). In July 2002, AcSEC issued for 
public comment an exposure draft of a proposed SOP, 
Accounting and Reporting by Insurance Enterprises for 
Certain Nontraditional Long-Duration Contracts and for 
Separate Accounts. During the 90-day comment period, 20 
comment letters were received by AcSEC.
Separate Account Presentation
A.2 Existing authoritative accounting guidance for separate ac­
counts is limited to paragraphs 53 and 54 of Financial Ac­
counting Standards Board (FASB) Statement of Financial 
Accounting Standards No. 60, Accounting and Reporting 
by Insurance Enterprises, and was written when contracts 
underlying the separate accounts generally were either 
fixed (having guaranteed returns) or variable (wherein the 
performance of the assets was the sole determinant of the 
return to the contract holder):
53. Separate accounts represent assets and liabilities 
that are maintained by an insurance enterprise for pur­
poses of funding fixed-benefit or variable annuity con­
tracts, pension plans, and similar activities. The contract 
holder generally assumes the investment risk, and the 
insurance enterprise receives a fee for investment man­
agement, certain administrative expenses, and mortality 
and expense risks assumed.
54. Investments in separate accounts shall be reported 
at market except for separate account contracts with 
guaranteed investment returns. For those separate ac­
counts, the related assets shall be reported in accordance
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with paragraphs 45-51. Separate account assets and lia­
bilities ordinarily shall be reported as summary totals in 
the financial statements of the insurance enterprise.
Paragraphs 45 through 51 of Financial Accounting Stan­
dards Board (FASB) Statement No. 60, Accounting and Re­
porting by Insurance Enterprises, provide guidance for 
valuing assets of the insurance enterprise’s general account 
(for example, FASB Statement No. 115, Accounting fo r  
Certain Investments in Debt and Equity Securities, for se­
curities, and FASB Statement No. 114, Accounting by 
Creditors for Impairment of a Loan, for mortgage loans), 
which for the remainder of this discussion will be referred 
to as “general account assets.”
A.3 Paragraph 54 of FASB Statement No. 60 has not been ap­
plied consistently in practice in terms of valuing assets 
maintained in separate accounts that have been deter­
mined to require valuation as general account assets, and 
in classifying the assets in the insurer’s statement of finan­
cial position. It is unclear whether the phrase “reported in 
accordance with paragraphs 45-51,” as used in paragraph 
54 of FASB Statement No. 60, refers only to valuation or 
whether it refers to statement of financial position single 
line presentation as well. Paragraph 54 of FASB Statement 
No. 60 states, “Separate account assets and liabilities ordi­
narily shall be reported as summary totals in the financial 
statements of the insurance enterprise.” Because separate 
account liabilities are classified consistent with the related 
asset classification, the issue of classification also affects 
separate account liabilities.
A.4 Although FASB Statement No. 60, as amended, requires 
separate account assets and liabilities to be reported in the 
financial statements of the insurance enterprise, AcSEC 
considered whether that guidance is consistent with recent 
standards addressing both asset and liability recognition 
and derecognition, such as FASB Statement No. 140, 
Accounting for Transfers and Servicing of Financial As­
sets and Extinguishments of Liabilities. AcSEC also con­
sidered potential analogies to similar trust fund and mutual 
fund products offered by the financial services industry. 
AcSEC noted that, unlike a financial institution trust fund
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account or mutual fund, the assets of the separate account 
are legally owned by the insurance enterprise. Addition­
ally, a separate account is not a separate legal entity under 
general corporate statutes. As noted in the AICPA Audit 
and Accounting Guide Life and Health Insurance Entities, 
“a separate account is a legally restricted fund that is seg­
regated from the life insurance entity. State insurance laws 
provide that assets in separate accounts may be invested 
without regard to restrictions covering general investments 
of life insurance entities. Separate account assets are gen­
erally not available to cover liabilities except those of the 
separate account.”
A.5 Thus, separate account assets may be isolated from the 
general creditors of the insurance enterprise, but not from 
the insurance enterprise itself, which still legally owns the 
assets. In a variable annuity or similar arrangement, there 
is no relinquishment of ownership of assets but rather the 
execution of a contract pursuant to which the insurance 
enterprise agrees to pass through the separate account in­
vestment results to the contract holder. Furthermore, the 
contract executed between the contract holder and the in­
surance enterprise creates an obligation of the insurance 
enterprise that is not defeased by the segregation of funds 
in the separate account. Based on the above, AcSEC con­
cluded that separate account assets and separate account 
liabilities should be reported in the statement of financial 
position of the insurance enterprise that owns the assets 
and is contractually obligated to settle the liabilities.
A.6 AcSEC considered whether it should ask FASB to recon­
sider the separate account asset and liability reporting re­
quirements of FASB Statement No. 60, as amended, in light 
of AcSEC’s conclusion in the SOP 00-3, Accounting by In­
surance Enterprises fo r Demutualizations and Forma­
tions of Mutual Insurance Holding Companies and fo r  
Certain Long-Duration Participating Contracts, that 
closed block assets, liabilities, and related statement of op­
erations activity should be displayed with the remainder of 
an insurance enterprise’s assets, liabilities, and statement 
of operations activity. AcSEC concluded that separate ac­
count structures differ in several significant respects from
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closed block structures: closed blocks do not legally insu­
late the assets supporting contract liabilities, closed block 
contract holders do not direct the investment of supporting 
assets, and individual closed block contract holders do not 
receive the direct pass-through of investment performance.
A.7 Collectively, the unique features of separate account 
arrangements warrant presentation distinct from an insur­
ance enterprise’s other assets and liabilities. AcSEC con­
cluded that summary account totals in the statement of 
financial condition and the offsetting of investment perfor­
mance and corresponding amounts credited to the con­
tract holder provide the most meaningful presentation to 
the users of the financial statements for contracts meeting 
the four criteria specified in paragraph 11 of this SOP. In 
addition, that presentation allows financial statement users 
to more readily analyze investment returns of insurance 
enterprises by excluding amounts that are legally insulated 
from the general account and not available to shareholders.
A.8 Separate accounts often are used in conjunction with non­
traditional products that have both fixed and variable fea­
tures. For example, variable annuity and variable life 
contracts frequently offer fixed rate investment options 
(typically through the insurer’s general account) and may 
provide contractually guaranteed benefits that are paid 
upon the death of the contract holder (minimum guaran­
teed death benefits) or at a specified date in the accumula­
tion phase of the contract (guaranteed minimum 
accumulation benefits). Those products have made it diffi­
cult to determine whether the criterion in paragraph 53 of 
FASB Statement No. 60, that “the contract holder generally 
assumes the investment risk,” has been met and thus 
whether assets and liabilities associated with such separate 
account arrangements should be classified as general ac­
count, separate account, or some combination of both. In 
addition, fixed contracts in which the insurance enterprise 
guarantees investment return or otherwise bears the in­
vestment risk may be offered through separate accounts, 
for example, as a means to provide additional credit pro­
tection to the contract holder.
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A.9 AcSEC believes that the emergence of new products has 
created a need for criteria to be developed for evaluating 
separate account arrangements and applying the guidance 
in paragraphs 53 and 54 of FASB Statement No. 60. AcSEC 
concluded that a defining characteristic of separate ac­
counts is their designation as such by appropriate regula­
tory bodies. AcSEC also believes that legal insulation of 
separate account assets, such that to the extent of contract 
holder liabilities, the assets would not be available to the 
general creditors and shareholders of the insurance enter­
prise in the event of insolvency, is a unique aspect of sepa­
rate account assets. AcSEC also concluded that a defining 
characteristic of separate accounts is that the contract 
holder dictates the allocation of deposits among invest­
ment alternatives and receives the pass-through of invest­
ment performance (that is, the contract holder receives 
the investment reward). In the case of certain group con­
tracts, this feature may take the form of the contract 
holder’s establishment of specific investment guidelines 
and objectives. AcSEC also noted that an implicit ceiling 
could exist through the use of certain sliding-scale perfor­
mance-based fees, thereby not meeting the criteria in para­
graph 11(d).
A.10 AcSEC considered whether only the assets and liabilities 
associated with the pure pass-through contracts offered 
through separate account arrangements, such as tradi­
tional variable annuities and other variable contracts that 
have neither guaranteed minimum death benefits nor ac­
cumulation guarantees, should be presented as single line 
items in the statement of financial condition of an insur­
ance enterprise. That treatment would require that the in­
surer not include in the separate account summary totals 
the assets and liabilities related to a contract if the insur­
ance enterprise bore any investment risk related to that 
contract. That view was rejected because the contract 
holder, rather than the insurance enterprise, controls the 
investments and is entitled to all the rewards of owning the 
assets underlying variable contracts. AcSEC concluded 
that separate account presentation for the portion of the 
separate account arrangement meeting the four criteria 
specified in paragraph 11 of this SOP is appropriate. Guar­
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antees on such contracts provided by the insurance enter­
prise are viewed as incremental contract benefits that may 
require recognition of any additional liability in the general 
account of the insurance enterprise.
A.11 Several respondents to the exposure draft expressed a 
view that the definition and proposed reporting of separate 
account arrangements in paragraph 11 of this SOP do not 
recognize the unique nature of certain non-U.S. products 
where legal insulation may not be achieved. AcSEC be­
lieves that the criteria for separate account treatment 
should be applied consistently to U.S. and non-U.S. prod­
ucts and that changes to the definition to permit classifica­
tion of certain non-U.S. products as separate accounts 
would inappropriately expand the use of separate account 
presentation to certain U.S. products. AcSEC reaffirmed 
that legal insulation is a key criterion for summary total 
presentation and statement of operations separate ac­
count treatment.
Accounting for an Insurance Enterprise's 
Interest in a Separate Account
A.12 When a separate account is established, the insurance en­
terprise may transfer non-contract-holder-related funds, 
commonly referred to as seed money, from its general ac­
count to the separate account to support the initial or on­
going operations of the separate account. Such transfers 
give the insurance enterprise an ownership interest in the 
separate account. The insurance enterprise’s interest may 
also include undistributed earnings on the seed money and 
contract charges that have not been transferred to the gen­
eral account.
A13. AcSEC recognized that there was diversity in practice re­
garding the classification and measurement of an insur­
ance enterprise’s proportionate interest in a separate 
account. Some insurance enterprises classified such 
amounts in the separate account caption along with sepa­
rate account assets attributable to contract holders. Other 
insurance enterprises reclassified such amounts to general 
account assets. In terms of measurement, some insurance
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enterprises marked separate account assets to market 
through income, including the insurance enterprise’s pro­
portionate interest, while others accounted for the insur­
ance enterprise’s proportionate interest as general account 
assets. Some insurance enterprises viewed the separate ac­
count as if it were a separate legal entity, and thus consid­
ered their portion of “separate account units” to be equity 
securities. Other insurance enterprises looked through the 
separate account arrangement and viewed their invest­
ment as a proportionate interest in the underlying mutual 
funds, debt and equity securities, mortgage loans, real es­
tate, or other assets in which the separate account arrange­
ment was invested.
A.14 AcSEC concluded that an insurance enterprise’s propor­
tionate interest in the assets of a separate account does not 
qualify for separate account treatment, as it does not rep­
resent contract holder funds. Consequently, the assets un­
derlying the insurance enterprise’s proportionate interest 
should be classified and measured as general account as­
sets in accordance with paragraphs 45 through 51 of FASB 
Statement No. 60, as amended.
A.15 AcSEC noted that a separate account is not a distinct legal 
entity under general corporate statutes, but rather an ac­
counting entity created by and under the control of the in­
surance enterprise that owns 100 percent of the assets. 
The insurance enterprise’s proportionate interest in the 
separate account typically would be available to general 
creditors in the event of the insurance enterprise’s insol­
vency. AcSEC concluded that an insurance enterprise’s 
proportionate interest in a separate account should not be 
viewed as an investment in “equity securities” of the sepa­
rate account. Instead, AcSEC concluded that the insurance 
enterprise should “look through” to the underlying invest­
ments held in the separate account for purposes of classifi­
cation and measurement as general account assets. In 
reaching that conclusion, AcSEC believed that assets 
should not be accounted for differently depending on 
whether an insurance enterprise has an interest in those 
assets through the general account or through the separate 
account (for example, fair value versus historical cost for 
real estate).
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A.16 Many respondents to the exposure draft commented on the 
complex and burdensome task of maintaining detailed 
records of daily percentage ownership of bonds or stocks or 
other investments as required under the SOP. While 
AcSEC continued to believe that the guidance noted in 
paragraph 11 is appropriate, AcSEC considered these com­
ments and decided to permit an insurance enterprise to ac­
count for its investment in a separate account as an 
investment in equity securities under FASB Statement No. 
115, Accounting for Certain Investments in Debt and Eq­
uity Securities, when the insurance enterprise’s propor­
tionate interest represents less than 20 percent of the 
separate account and the underlying separate account in­
vestments are securities under Statement No. 115 or para­
graph 46 of FASB Statement No. 60, as amended by FASB 
Statement No. 115, or cash and cash equivalents. AcSEC 
acknowledged that there should not be a difference be­
tween the aggregate fair value of the individual securities 
and a proportionate share of the fair value of the aggregate 
investments in the separate account. Therefore, in these 
limited situations, the cost appeared to outweigh the com­
mensurate benefit of applying the proposed guidance.
A.17 AcSEC also acknowledged that under this alternative an in­
surance enterprise should perform an impairment test on 
the value of the interest in the separate account (or indi­
vidual subaccounts, as applicable). AcSEC believes it 
would not be appropriate to allow this alternative for cir­
cumstances where the underlying separate account invest­
ments are other than securities under FASB Statement No. 
115 or paragraph 46 of FASB Statement No. 60, as 
amended by FASB Statement No. 115, or cash and cash 
equivalents, such as mortgage loans or real estate, as the al­
ternate method would result in different bases of account­
ing. AcSEC concluded that to apply the alternate method 
the underlying separate account investment related to the 
insurance company’s proportionate interest should be clas­
sified as trading with changes flowing through the income 
statement, as classification as available for sale would defer 
the recognition of investment income.
A.18 Contract holders may have the right to continue to make 
deposits and direct transfers of their account balances, and
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new contract holders are permitted to invest in the various 
separate account arrangements. In those cases, the insur­
ance enterprise is effectively holding for sale its propor­
tionate interest in the separate account assets if those 
separate account arrangements would meet the criteria in 
paragraph 11 of this SOP. Consequently, the insurance en­
terprise should recognize an impairment loss on its propor­
tionate interest in the assets of a separate account 
arrangement meeting the criteria in paragraph 11 in a situ­
ation where the current fair value of the insurance enter­
prise’s proportionate interest in the separate account 
assets is less than its carrying amount.
Transfers to Separate Accounts
A.19 AcSEC concluded that transfers of assets to separate ac­
counts should be recognized at fair value to the extent of 
third-party contract holders’ interests in the separate ac­
count if the separate account arrangement meets the crite­
ria in paragraph 11 of this SOP, with any resulting gains or 
losses recognized immediately in earnings of the insurance 
enterprise. Gain or loss recognition is appropriate in such 
cases because the contract holders are unrelated third par­
ties to whom subsequent risks and rewards of ownership of 
a portion of the asset have been transferred, and the assets 
will subsequently be carried at fair value with changes re­
ported in earnings (offset by changes in contract holder li­
abilities). Furthermore, although the insurance enterprise 
holds legal title to assets in separate account arrangements, 
the contract holders will be entitled to receive the invest­
ment performance of the assets after the transfer. This 
treatment is consistent with the presentation of separate 
account assets as summary totals in the statement of finan­
cial position, because the risks and rewards of ownership of 
the assets reside with the contract holders rather than the 
insurance enterprise that has legal ownership of the assets. 
If the insurance enterprise guarantees the asset’s value or 
minimum rate of return or commits to repurchase the 
asset, the risks of ownership have not been transferred, 
and no gain should be recognized. However, loss recogni­
tion is still appropriate as noted in paragraph A.18 of this
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SOP. AcSEC concluded that in the limited circumstances 
where the alternate method, as described in paragraph 18 
of this SOP, is applied, 100 percent of any gain on transfers 
of assets to separate accounts should be recognized as the 
underlying investments are designated as trading. AcSEC 
had already concluded that all losses were required to be 
recognized for transfers of assets to separate accounts.
A.20 For separate account arrangements for which the insur­
ance enterprise is actively marketing units and hold real 
estate, AcSEC concluded that, in cases in which the held 
for sale criteria for real estate are not met, the impairment 
test should be performed solely using cash flows from ulti­
mate disposition. Cash flows related to the use of the asset 
during the period preceding ultimate disposition should be 
zero because the enterprise does not have control over the 
dilution of its interest.
Valuation of Liabilities
A.21 Account balance. Paragraph 17(a) of FASB Statement No. 
97, Accounting and Reporting by Insurance Enterprises 
fo r  Certain Long-Duration Contracts and for Realized 
Gains and Losses from the Sale of Investments, does not 
explicitly define “the balance that accrues to the benefit of 
policyholders at the date of the financial statements,” 
which is commonly referred to as the “account balance.” 
FASB Statement No. 97, paragraph 18, provides that the 
account balance is an amount that should not be reduced 
for “amounts that may be assessed against policyholders in 
future periods, including surrender charges....”
A.22 AcSEC also noted that FASB Statement No. 97 defines con­
tract holder balance indirectly through the following:
Premium payments are credited to the policyholder bal­
ance, against which amounts are assessed for contract 
services and to which amounts are credited as income.
The policyholder balance provides a base upon which in­
terest accrues to the policyholder and, when compared 
with the death benefit amount, fixes the insurer’s net 
amount at risk. [paragraph 45]
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...the balance that accrues to the benefit of individual 
policyholders represents the minimum measure of an in­
surance enterprise’s liability.... For many universal life- 
type contracts, this amount takes the form of an account 
balance that, absent future action by the policyholder, 
will continue to fund operation of the contract until ex­
hausted or reduced to a contract minimum. The insurer 
has a present obligation, arising from past transactions, 
to continue to maintain the contract and provide mortal­
ity protection as long as an adequate account balance ex­
ists. Other universal life-type contracts do not have an 
explicit policyholder account but do have a policyholder 
balance to which interest is accrued at a variable rate. In 
either case, future events and transactions will change 
the amount of the enterprise’s obligation as policyhold­
ers make additional premium deposits and realize con­
tract benefits. The present obligation, however, is fixed 
by the amount that has accrued to the benefit of the pol­
icyholder. [paragraph 53]
Recent product innovation and the lack of explicit guid­
ance has led to diversity in the application of the definition 
of account balance. AcSEC therefore believes that inter­
pretive guidance is needed for determining the balance 
that accrues to the benefit of the policyholder at the date of 
the financial statements.
A.23 AcSEC concluded that all surrender charges or credits 
should be ignored in measuring the policyholder liability 
because, as noted in FASB Statement No. 97, paragraphs
18 and 53, the liability should be measured assuming no fu­
ture action by the policyholder. FASB Statement No. 97 is a 
long-duration contract model that does not assume policy­
holders will surrender at the balance sheet date but rather 
amortizes deferred acquisition costs over the expected life 
of the contract. Additionally, the FASB Statement No. 60, 
as amended, and FASB Statement No. 97 accounting mod­
els do not require that the contract holder liability, net of 
unamortized acquisition costs, equal or exceed the cash 
surrender value of the contract. AcSEC considered 
whether the presence of an additional amount due on sur­
render but not due upon maturity, such as a market value 
annuity adjustment, should result in the recognition of an 
additional liability. AcSEC concluded that recording an ad­
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ditional liability for surrender adjustments prior to the 
contract holder’s elected surrender would be inconsistent 
with the long-duration model.
A.24 AcSEC concluded that, in accordance with FASB State­
ment No. 97, it is appropriate to accrue to the amount that 
the contract holder could receive in cash or its equivalent, 
before reduction for future fees and charges, at the earlier 
of the date that the rate credited to the contract is reset or 
contractual maturity. That conclusion is consistent with 
the long-duration model, which does not permit the antici­
pation of surrenders and also with the accounting for debt 
instruments, under which interest is accrued to maturity 
using the interest method. Accrual of interest at an effec­
tive interest rate is consistent with existing accounting for 
debt instruments with fixed nonlevel interest payments. A 
delay in crediting to the contract holder account balance 
an amount that is to be credited in the future should not 
prevent the accrual of the amount ratably over the period 
the contract holder earns the amount.
A.25 AcSEC believes that a contract in which the amount due at 
maturity is based on a referenced pool of assets is similar 
to indexed debt, which prior to FASB Statement No. 133, 
Accounting fo r Derivative Instruments and Hedging Ac­
tivities, was accounted for in accordance with Emerging Is­
sues Task Force (EITF) Issue No. 86-28, Accounting 
Implications of Indexed Debt Instruments. EITF Issue No. 
86-28 provides the following accounting guidance:
... as the applicable index increases such that the issuer 
would be required to pay the investor a contingent pay­
ment at maturity, the issuer should recognize a liability 
for the amount that the contingent payment exceeds the 
amount, if any, originally attributed to the contingent 
payment feature. The liability for the contingent pay­
ment feature should be based on the applicable index 
value at the balance sheet date and should not anticipate 
any future changes in the index value. When no proceeds 
are originally allocated to the contingent payment, the 
additional liability resulting from the fluctuating index 
value should be accounted for as an adjustment of the 
carrying amount of the debt obligation.
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Therefore, AcSEC concluded that, to the extent such con­
tracts are not accounted for under the provisions of FASB 
Statement No. 133, the balance that accrues to the benefit 
of the contract holder should be based on the fair value of 
the referenced pool of assets because the change in the fair 
value of the referenced pool of assets represents the change 
in the account balance. To the extent the amount credited 
does not equal the change in fair value of the referenced 
pool of assets, an adjustment as described in paragraph 
20(e) of this SOP would be required. Many respondents to 
the exposure draft commented that this guidance would re­
sult in misleading volatility and a mismatch in the financial 
statements when the referenced assets are not also 
recorded at fair value. AcSEC reaffirmed the liability model 
in this SOP and noted that changing the valuation of in­
vestments was not within the scope of this project.
Contracts W ith Death or Other Insurance 
Benefit Features
A.26 Determination of applicable accounting standard. AcSEC 
decided the FASB Statement No. 97 universal life model 
should apply to insurance benefit features only if (a) the 
fees assessed or the benefits provided are not fixed and 
guaranteed, and (b) the mortality and morbidity risks are 
other than nominal. Those contracts having insurance 
benefit features where the fees assessed and the benefits 
provided are fixed and guaranteed should be accounted for 
under FASB Statement No. 60, as amended. Those insur­
ance benefit features that do not pass the test of signifi­
cance result in the contracts being classified as 
investment-type contracts under FASB Statement No. 97, 
and no additional liability for insurance benefits should be 
provided, other than a claim liability resulting from the oc­
currence of the insurance event.
A.27 Determining the significance of mortality and morbidity 
risk. AcSEC considered how the test of significance of mor­
tality and morbidity risk should be applied to contracts 
with insurance benefit features. The significance test con­
tained in paragraph 8 of FASB Statement No. 97 is based on 
the present value of the expected life contingent payments
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relative to the present value of all expected payments. 
AcSEC considered whether that test should be modified for 
insurance benefit features offered with annuity contracts. 
The test was written for payout annuities for which the en­
tire deposit may be subject to mortality risk. For accumu­
lation-phase annuity contracts containing insurance 
benefit features, the contract has a deposit element, which 
under all circumstances the contract holder will receive, 
and a mortality and morbidity element for payments in ex­
cess of the deposit element. AcSEC decided that because 
the timing and nature of benefit payments are different be­
tween payout annuities and an accumulation-phase annu­
ity with a minimum guaranteed death benefit (MGDB) or 
other insurance benefit feature, the measurement of the 
significance of the mortality related payments needed to be 
modified. AcSEC believes a better method to determine 
significance for these contracts is to compare the present 
value of expected insurance benefit excess payments with 
the fee revenue or spreads the insurance enterprise will 
collect for accepting that and other risks.
A.28 AcSEC considered whether the test of significance should 
be performed only at the inception of the contract or 
throughout the life of the contract. It was noted that per­
forming the test throughout the life of the contract could 
result in situations where contracts would switch from one 
accounting model to another and potentially back again as 
the estimate of expected benefit costs changed. AcSEC de­
cided to require the test of significance to be performed 
only at the inception of the contract or reinsurance con­
tract, noting that it is consistent with current practice for 
applying the test for classifying payout annuities under 
FASB Statement No. 97. Similarly, the comparison of the 
timing of expected assessments and related benefits for de­
termining whether the amounts assessed against the con­
tract holder each period for the insurance benefit feature 
are assessed in a manner that is expected to result in prof­
its in earlier years and losses in subsequent years from the 
insurance benefit function would occur at inception only, 
as well. As discussed in the transition section of this SOP, 
an exception is made for contracts in force at the date of
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transition for which the test of significance would be per­
formed as of transition.
A.29 For certain contracts with insurance benefit features, such 
as MGDBs offered with variable annuities, the expected 
benefit costs or the expected revenue vary with market el­
ements such as interest rates or the performance of an un­
derlying pool of equities. AcSEC considered whether to 
require expected benefit costs and expected revenue to be 
determined based on a single set of assumptions or a range 
of results. AcSEC decided that the test of significance 
should be based on models that use more than a single set 
of assumptions, because that approach would better reflect 
the effect of market elements on both expected benefit 
costs and expected revenue. This approach is consistent 
with FASB Statement of Financial Accounting Concepts 
No. 7, Using Cash Flow Information and Present Value in 
Accounting Measurements, which concludes that expected 
values are more useful for present value calculations, and is 
further supported by FASB Statement No. 113, Accounting 
and Reporting for Reinsurance of Short-Duration and 
Long-Duration Contracts, which states that when evaluat­
ing the possibility of the reinsurer incurring a loss, reason­
ably possible scenarios should be considered. Because the 
test of significance requires consideration of a range of sce­
narios and the market is inherently volatile, AcSEC con­
cluded that there is a rebuttable presumption that a 
contract with an insurance benefit that varies significantly 
in response to capital market volatility has significant mor­
tality risk.
A.30 Establishment of an additional liability. AcSEC consid­
ered whether, under the universal life model of FASB State­
ment No. 97, a separate liability in addition to the account 
balance should be recognized. AcSEC noted that FASB 
Statement No. 97, paragraph 17, states:
The liability for policy benefits for universal life-type 
contracts shall be equal to the sum of:
a. The balance that accrues to the benefit of policyhold­
ers at the date of the financial statements
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b. Any amounts that have been assessed to compensate 
the insurer for services to be performed over future 
periods (paragraph 20)
c. Any amounts previously assessed against policyhold­
ers that are refundable on termination of the contract
d. Any probable loss (premium deficiency) as described 
in paragraphs 35-37 of Statement No. 60. [Footnote 
omitted]
A.31 AcSEC noted that the universal life model under FASB 
Statement No. 97 requires additional liabilities for revenue 
assessed for services to be performed in future periods and 
any probable future loss (premium deficiency). In studying 
the attributes of contracts with insurance benefit features, 
AcSEC observed that, in some contracts, periodic charges 
are not assessed in proportion to the risk associated with 
these benefit features. For example, charges may be as­
sessed for a ratchet MGDB offered with variable annuities 
based on a percentage of the account balance. In such an 
MGDB design, as the account balance and assessments in­
crease, the likelihood of a death benefit payment in excess 
of the account balance decreases. AcSEC noted that FASB 
Statement No. 97, paragraph 61, states, “An amount as­
sessed might be considered unearned, for example, if it is 
assessed only in certain contract periods or in a manner 
that is expected to result in current profits and future 
losses from a specific contract function.” AcSEC concluded 
that, for contracts where amounts are assessed in a man­
ner that is expected to result in current profits and future 
losses from the insurance benefit function, a liability 
should be established in addition to the account balance. 
This conclusion is also appropriate when considering the 
reinsurer that assumes, under a long-duration contract, the 
MGDB risk for a level basis point charge but does not as­
sume the account balance. Without this conclusion, the 
reinsurer would be recognizing revenue without the related 
expected benefit cost.
A.32 AcSEC also considered, but rejected, the view that an addi­
tional liability for expected losses on insurance benefit 
payments would only be established if all the margins of 
the product combined to create a premium deficiency. The 
premium deficiency concept would in most cases result in
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no additional liability being established and all amounts as­
sessed during the period being recognized in income even 
for assessments that are clearly not proportionate to the 
risk borne by the insurance enterprise for the period. 
AcSEC rejected that view because such disproportionate 
assessments are made in part to compensate the insurance 
enterprise for the risk it assumes in future periods.
A.33 In calculating the liability for the insurance benefit feature, 
AcSEC decided it is appropriate to use assumptions, such 
as the interest rate, lapse rate, and mortality, consistent 
with those used in estimated gross profits and conse­
quently the amortization of deferred acquisition costs. This 
approach is supported by paragraph 20 of FASB Statement 
No. 97.
A.34 Due to multiple contractual designs, some of which may in­
clude no explicit fee for the insurance benefit feature, 
AcSEC concluded that the liability in addition to the ac­
count balance should be based on total assessments, in­
cluding investment spread, to eliminate different design 
features receiving different accounting treatment. This ap­
proach implicitly assumes that the assessment each period 
for the insurance benefit feature is a level amount of the 
total basis point charge. AcSEC noted that this approach is 
relatively easy to apply for all contracts even if there is not 
a separate explicit charge in the contract for the insurance 
benefit feature. If there is a separate explicit charge for the 
insurance benefit feature, AcSEC believes it is appropriate 
to determine the liability using total assessments because 
it will result in more consistent application of the method­
ology. In situations where expenses included in estimated 
gross profits are proportionate to assessments, AcSEC un­
derstands that the use of estimated gross profits instead of 
assessments for purposes of determining the benefit ratio 
may produce consistent results.
A.35 The additional liability is in substance an FASB Statement 
No. 60 policyholder benefit liability, but with the unlocking 
of assumptions each period as required under FASB State­
ment No. 97 to recognize the variability of the insurance 
benefit payments and contract assessments. That is, the 
FASB Statement No. 60 policy benefits liability is calcu­
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lated as the present value of future expected benefits and 
related expenses minus the present value of future net pre­
miums. In substance, the FASB Statement No. 60 approach 
is a type of unearned revenue model, although the policy­
holder benefit liability does not include a profit margin, in 
that it provides for the addition to the policyholder benefit 
reserve each period of a constant percentage of gross pre­
mium. AcSEC considered whether the additional liability 
should be reflected as unearned premium. The concept of 
unearned revenue includes an element of profit margin, 
other than in an FASB Statement No. 60 policyholder ben­
efit liability. Allocation of profit to specific contract fea­
tures such as an MGDB would require allocation of costs 
across all product features. Such analysis would require 
further actuarial modeling of costs for other product fea­
tures considering a range of assumptions, which would add 
substantial effort to the determination of the MGDB liabil­
ity. Such analysis to ascertain a profit margin for each ben­
efit feature reconciling to the total profit margin for the 
contract introduces further subjectivity into the liability 
determination. The additional liability required in this SOP 
is based on the relationship of total expected benefits and 
related expenses to total expected revenue and thus is con­
sistent with the FASB Statement No. 60 policyholder bene­
fit liability with the unlocking of assumptions each period 
to be consistent with FASB Statement No. 97. Therefore 
AcSEC concluded that, because profit margin was not 
being considered in the calculation, the best presentation 
of the liability would be as a policyholder benefit liability.
A.36 Statement of operations presentation. AcSEC considered 
whether changes in the liability for insurance benefit fea­
tures offered with annuity contracts should be reflected in 
the statement of operations as an increase or decrease in 
revenue or expense. AcSEC concluded for the reasons 
mentioned in paragraph A35 of this SOP that the change in 
the liability should be reported as a benefit expense consis­
tent with changes in policyholder benefit liabilities under 
FASB Statement No. 60.
A.37 Accounting for contracts that provide only death or other 
insurance benefit features. FASB Statement No. 113, para­
graph 12, requires that, for long-duration contracts, the
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reinsurance contract subjects the reinsurer to the “reason­
able possibility that the reinsurer may realize significant 
loss from assuming insurance risk as that concept is con­
templated in FASB Statement Nos. 60 and 97.” Therefore, 
AcSEC concluded that the reinsurer should follow the 
same guidance as a direct writer when testing for signifi­
cance of mortality and morbidity risk and when accounting 
for the insurance benefit feature.
Accounting for Contracts That Provide 
Annuitization Benefits
A.38 Certain variable annuities provide a guaranteed minimum 
amount available to annuitize after a specified period in ad­
dition to a guaranteed minimum annuity interest rate. 
Other contracts may provide a lower-tier crediting rate 
during the accumulation phase and a higher rate that is 
available only upon annuitization. There was diversity in 
practice with regard to the accounting for these and other 
annuitization options.
A.39 The conclusion in the exposure draft of the proposed SOP 
was that no liability should be recognized during the accu­
mulation phase of a contract for the potential effect of an­
nuitization options. This view was based on AcSEC’s initial 
interpretation of FASB Statement No. 97, paragraph 7, 
which states in part that “a contract provision that allows 
the holder of a long-duration contract to purchase an an­
nuity at a guaranteed price on settlement of the contract 
does not entail a mortality risk until the right to purchase 
is executed. If purchased, the annuity is a new contract to 
be evaluated on its own terms.” AcSEC had initially con­
cluded that those words precluded accounting recognition 
of an annuitization option before the option is exercised. 
However after further discussion, AcSEC concluded that 
the language in paragraph 7 could be interpreted to apply 
only to testing for the presence of mortality risk, and not to 
preclude recognition of a liability. Supporters of this latter 
view note that FASB Statement No. 97 states in paragraph 
40 that “the risk that the guaranteed price of an annuity 
may prove to be unfavorable to the guaranteeing enterprise 
when the annuity is purchased is a price risk not unlike a
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guaranteed price of any commodity and does not create a 
mortality risk [emphasis added] .” Supporters of accruing 
an additional liability believe that, although that guidance 
prohibits accounting for the contract as if the payout phase 
were elected and mortality risk existed, it acknowledges the 
existence of price risk inherent in the annuitization option, 
thereby allowing for the recognition of the effect of signifi­
cant annuitization options in the accumulation phase.
A.40 A majority of respondents to the exposure draft of the pro­
posed SOP noted that the exposure draft’s initial conclu­
sion to not accrue the costs related to annuitization 
options would, in many instances, result in an accounting 
treatment that does not appropriately reflect the econom­
ics of the product. Some noted that the financial statement 
result could be recognition of earnings during the accumu­
lation phase followed by losses during the annuitization 
phase of the contract. Respondents noted that establishing 
a liability for these features would be consistent with fun­
damental generally accepted accounting principles con­
cepts, including the definition of a liability, unearned 
income, and loss recognition. AcSEC redeliberated the 
issue and ultimately concluded that the guidance in para­
graph 7 of FASB Statement No. 97 should, therefore, be in­
terpreted to require the recognition of a liability related to 
any such options that are other than nominal, reversing 
the conclusion reached in the exposure draft of the pro­
posed SOP. AcSEC members believe that recording a liabil­
ity during the accumulation phase of a contract for 
expected annuitization benefits would better reflect the 
economics of the contract. Some amount of revenue or fees 
was explicitly, or in some cases implicitly, being charged 
for this additional contract feature; therefore, the cost of 
providing the potential future benefits should also be rec­
ognized in the accumulation phase. Such additional bene­
fits can be clearly and materially favorable to the contract 
holder and thus represent a loss contingency that is both 
probable and reasonably estimable. The obligation to pro­
vide a service/benefit under an annuitization guarantee 
also meets the definition of a liability under FASB Concepts 
Statement No. 6, Elements of Financial Statements.
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A.41 AcSEC noted that annuitization benefits are similar in 
many respects to MGDBs in that they provide an additional 
benefit beyond the account balance. For example, both the 
MGDB and guaranteed minimum income benefit (GMIB) 
features represent a minimum guaranteed amount on a 
variable account balance, with the principal difference 
being that one is promised upon death, the other upon an­
nuitization. Based on this similarity to MGDB, AcSEC con­
cluded that the MGDB model should be used to accrue an 
additional liability for GMIB if, at the expected annuitiza­
tion date, the present value of expected annuitization pay­
ments exceeds the expected accrued account balance. In 
addition, AcSEC noted that if an insurance enterprise has 
reinsured the GMIB risk, in many instances the reinsur­
ance contract results in a derivative recognized as an asset 
on the statement of financial condition. If the GMIB liabil­
ity was not recognized, stockholders’ equity would be in­
creased, when in fact that asset is substantially offset by an 
unrecorded liability. However, AcSEC observed that the 
GMIB liability recognized under the guidance in this SOP 
will not be measured at fair value and therefore would not 
necessarily offset the reinsurance asset.
A.42 In reaching a conclusion relative to accounting for annuiti­
zation option benefits, AcSEC considered several alterna­
tive models, including the loan commitment and written 
option models. AcSEC’s consideration of those models is 
discussed in the following paragraphs of this SOP.
A.43 Consideration of the loan commitment model. AcSEC con­
sidered an analogy between annuitization options provided 
to contract holders and loan commitments offered to bor­
rowers, the accounting for which is prescribed by FASB 
Statement No. 91, Accounting for Nonrefundable Fees and 
Costs Associated with Originating or Acquiring Loans 
and Initial Direct Costs of Leases, which effectively defers 
revenue recognition until the economic sacrifice has oc­
curred. FASB Statement No. 91 states in paragraph 8 that 
“fees received for a commitment to originate or purchase a 
loan or group of loans shall be deferred and, if the commit­
ment is exercised, recognized over the life of the loan as an 
adjustment of yield....” Under this analogy, all fees related 
to an annuitization option should be deferred until the con­
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tract holder selects an annuity option; the fees would then 
be recognized over the payout phase of the annuity or, if 
annuitization was not elected, recognized in income at the 
date the contract is surrendered.
A.44 AcSEC believes that problems would arise in applying the 
loan commitment model to annuity contracts. First, it 
would be difficult to reasonably determine which fees 
should be deferred within a fee-based product as the fees 
related to the annuitization guarantee often are not stated 
explicitly, or even if stated explicitly, may have been priced 
on an integrated basis with other revenue components 
within the contract rather than on a stand-alone basis. 
Also, it is unclear how to apply this model to products 
where the insurance enterprise derives its income from in­
vestment spreads and thus the contracts have no explicit 
fee of any kind to defer.
A.45 In addition, AcSEC noted that there are differences be­
tween annuitization options and loan commitments. Annu­
itization options are of a long-term nature (for example, the 
contract holder may have until age 65, 80, or 90 to annu­
itize), whereas a loan commitment is generally for a much 
shorter period. Also, in deciding whether or not to annu­
itize, there are additional economic factors that contract 
holders must consider, such as alternative investment op­
tions, cash flow considerations, their tax situations, and 
needs of beneficiaries. Those factors are not relevant to the 
process of taking a loan, as the commitment is entered into 
with the intent to borrow and the principal decision is 
whether the loan terms are competitive. In view of the sig­
nificant practical implications and many differences be­
tween annuitization options and loan commitments, AcSEC 
decided to reject the FASB Statement No. 91 approach in 
accounting for annuitization and similar elective benefits.
A.46 Consideration of the written option model. AcSEC also 
considered whether elective benefit options should be ac­
counted for as written options by recording the fair value of 
the options both at inception and throughout the accumu­
lation phase of the contract, with changes in fair value rec­
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ognized in income. Supporters of this view believe that 
similar to the conclusion reached by AcSEC as noted in 
paragraph A37 of this SOP, the guidance in paragraph 7 of 
FASB Statement No. 97 should be interpreted to require 
the recognition of a liability related to any such options.
A.47 AcSEC also noted that under FASB Statement No. 133, 
reinsurance of a GMIB option typically would be ac­
counted for as a derivative contract by both the direct 
writer of the deferred annuity contract with the GMIB fea­
ture (ceding company) and the reinsurer, as such reinsur­
ance contracts are typically net settled. Also, although the 
FASB concluded that certain annuitization options such as 
GMIBs offered in direct annuity contracts typically are not 
net settled and therefore fall outside the scope of FASB 
Statement No. 133, some argue that there are other writ­
ten options that fall outside the scope of FASB Statement 
No. 133 that nevertheless are required to be fair valued. 
For example, EITF Issue No. 99-2, Accounting for Weather 
Derivatives, requires fair value for certain written options 
even though they fall outside the scope of FASB Statement 
No. 133. However, those are examples of contracts falling 
outside of the scope of Statement No. 133 that represent 
written options in their entirety and not a component em­
bedded in a contract.
A.48 It was also noted that following the approach of valuing all 
elective options at fair value would be a change in practice 
and would require insurance enterprises to determine the 
fair value of every available annuitization option. Tradi­
tional annuity purchase options may have little value, but 
it would be necessary to continuously determine their 
value. AcSEC also discussed the issues of the lack of a 
ready market to determine the fair value of the annuity op­
tions because each contract’s features are unique by prod­
uct as well as by insurance enterprise, and of the difficulty 
involved in splitting apart an integrated fee-based contract 
to determine applicable fees representing the implicit op­
tion premium received, adding to the practical problems of 
applying this approach.
47
Sales Inducements to Contract Holders
A.49 Sales inducements to contract holders typically can be 
characterized as one of the following types: immediate, 
persistency, and enhanced crediting rate. The actual struc­
ture of the inducement can take many forms. Economi­
cally, recovery of the costs associated with sales 
inducements is predicated on a future income stream of 
items such as fees charged against the assets, investment 
margins, surrender charges, cost of insurance charges, or 
reduction of other cost components. In some cases, insur­
ance enterprises may accept lower margins on the product. 
Sales inducements may be part of an arrangement whereby 
the sales agent is willing to accept lower commissions, 
which may offset some or all of the associated cost. In 
some cases, inducement programs may be initiated to pre­
vent recognition of more dramatic losses if the insurance 
enterprise is unable to retain contract holders (for exam­
ple, the insurance enterprise may be required to sell in­
vestments at a loss to fund contract surrenders).
A.50 Consideration of the debt model. Asset accumulation 
products accounted for under FASB Statement No. 97 as 
investment products or universal life-type contracts are 
viewed as financial instruments. The insurance enterprise 
has a contractual obligation to deliver cash and the cus­
tomer has a contractual right to receive cash. Paragraph 
15 of FASB Statement No. 97 requires that investment 
contracts issued by an insurance enterprise be accounted 
for in a manner consistent with the accounting for inter­
est-bearing instruments.
A.51 AcSEC believes instruments issued by financial institu­
tions should be accounted for consistently, as noted in 
FASB Statement No. 97, paragraph 39: “While many invest­
ment contracts are issued primarily by insurance enter­
prises, the Board believes that similar financial 
instruments should be accorded similar treatment regard­
less of the nature of the issuing enterprise.” In connection 
with an immediate inducement, cash is given to the insur­
ance company in exchange for a promise to pay back an 
amount in excess of the cash received. Persistency and en­
hanced inducements are also analogous to nonlevel inter­
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est on fixed income securities. FASB Statement No. 91 re­
quires that fees or costs be recognized as yield adjustments 
over the life of the contract by the interest method of 
recognition for nonlevel interest. AcSEC concluded that 
sales inducements meeting the criteria in paragraph 37 of 
this SOP should result in an effective yield being recog­
nized over the expected life of the contract, rather than ex­
pensing the persistency and enhanced interest rate 
inducements as amounts are credited to the contract 
holder. This treatment will result in recognition of the sales 
inducement as it is accrued or when it is credited to the ac­
count balance, whichever is earlier.
A.52 Consideration of sales inducements as deferred acquisi­
tion costs. AcSEC considered the arguments in favor of ac­
counting for sales inducements as a deferred acquisition 
cost. Insurance companies price the products based on 
total cash inflows and outflows. Some argued that the form 
of the transaction that splits these outflows between agent 
and the customer should be of no consequence, and the 
substance of the transaction is that certain outflows are 
paid to induce the customer to acquire the product. AcSEC 
concluded that sales inducements do not meet the defini­
tion of a deferrable acquisition cost because they are bene­
fits paid to contract holders, not payments to third parties.
A.53 Criteria for capitalization. AcSEC considered the criteria 
for determining when a sales inducement is in excess of 
normal crediting rates that would warrant capitalization. 
AcSEC believed it was necessary for an insurance enter­
prise to explicitly demonstrate that such amounts are (a) 
incremental to amounts the enterprise credits on similar 
contracts without sales inducements, and (b) higher than 
the contract’s expected ongoing crediting rates for periods 
after the inducement; that is, the crediting rate excluding 
the inducement should be consistent with assumptions 
used in estimated gross profits, contract illustrations, and 
interest crediting strategies. These criteria are necessary to 
prevent capitalization of interest crediting amounts that 
are current period benefit expenses.
A.54 AcSEC believes that in determining whether an enhanced 
crediting rate is incremental to amounts the enterprise
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credits on similar contracts, an insurance enterprise 
should compare the enhanced crediting rate with the cur­
rent rate offered on a similar product sold without a sales 
inducement, if available. In cases where a similar product 
is not actively marketed and sold without the enhanced 
crediting rate, AcSEC believes the enterprise should 
demonstrate that the enhanced crediting rate is incremen­
tal to the effective crediting rate on the enterprise’s other 
product(s) that have common characteristics and sub­
stance. For example, variable annuities may offer a fixed 
return over a six-month period until the funds are trans­
ferred into equity funds (dollar cost averaging options). 
The fixed return is often in excess of the interest rate cred­
ited on other variable annuity general account fixed in­
come investment alternatives of similar duration that are 
actively marketed and sold by the enterprise. The excess 
interest rate would meet the criterion in paragraph 37 of 
this SOP of “incremental to amounts the enterprise credits 
on similar contracts without sales inducements.”
A.55 Normally day-one and persistency bonuses would meet the 
criteria in paragraph 37 of this SOP, because crediting occurs 
on a specific date and thus the bonus would be incremental 
to other similar contracts with a different anniversary.
A.56 Consideration of expensing sales inducements in the pe­
riod credited. AcSEC also considered and rejected the view 
that benefits payable to contract holders should be charged 
to benefit expense in the period credited to the contract 
holder consistent with other benefit payments. Under this 
method, AcSEC noted that sales inducements would be 
recorded as a liability to the customer at the time they 
meet the definition of a liability, with an immediate charge 
to expense as a benefit cost.
A.57 AcSEC recognized the long-duration nature of the con­
tracts as defined in FASB Statements No. 60 and No. 97 and 
was concerned that expensing sales inducements in the pe­
riod credited could lead to different accounting for con­
tracts that are economically similar. AcSEC noted that 
contract wording could easily be changed to obtain differ­
ent accounting treatments. For example, contracts with 
identical economic benefits to the contract holder could be
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designed, one with an immediate bonus with a surrender 
charge expiring after five years and one with a persistency 
bonus credited at the end of five years. Expensing sales in­
ducements in the period credited would result in very dif­
ferent accounting results even though the contracts were 
identical economically and would result in loss at inception 
on the contract that offered an immediate sales induce­
ment. Another contract with a persistency bonus would 
give the contract holder the same cash in the future and 
not have a loss at inception. Based on those concerns, 
AcSEC rejected the concept of expensing sales induce­
ments in the period credited and concluded to expense 
sales inducements over the period that the long-duration 
contract is in force.
A.58 Amortization of deferred sales inducements. For contracts 
accounted for under FASB Statement No. 97, the asset aris­
ing from sales inducements should be amortized using 
methodology and assumptions consistent with those used 
for deferred acquisition costs under FASB Statement No. 
97, which is effectively the expected life of the accumula­
tion phase of the contract. Because FASB Statement No. 97 
requires that the annuitization phase be viewed as a sepa­
rate contract, the annuitization phase should not be com­
bined with the accumulation phase. AICPA Practice 
Bulletin 8, Application of FASB Statement No. 97, Ac­
counting and Reporting by Insurance Enterprises for Cer­
tain Long-Duration Contracts and for Realized Gains and 
Losses from the Sale of Investments, to Insurance Enter­
prises, states:
The amortization method described in FASB Statement 
No. 97 for universal life-type contracts should be used for 
investment contracts that include significant surrender 
charges or that yield significant revenue from sources 
other than the investment of contract holders’ funds. 
This method matches amortization of deferred policy ac­
quisition costs (DPAC) with the recognition of gross prof­
its. Otherwise, DPAC on investment contracts should be 
amortized using an accounting method that recognizes 
acquisition and interest costs as expenses at a constant 
rate applied to net policy liabilities and that is consistent 
with the interest method under FASB Statement No. 91,
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Accounting for Nonrefundable Fees and Costs Associ­
ated With Originating or Acquiring Loans and Initial 
Direct Costs of Leases (interest method).
This guidance is provided for the amortization of deferred 
acquisition costs, which in this context is similar to debt is­
suance costs.
A.59 AcSEC considered, but rejected, the view that a qualifying 
sales inducement should be amortized over the shorter of 
the expected life of the contract or the period during 
which the sales inducement is effectively operating to in­
cent persistency. As the recovery of sales inducements is 
through future income streams [such as fees charged 
against the assets, investment margins, cost of insurance 
charges, reduction of other cost components (such as 
commissions), or surrender charges] during the expected 
contract life, AcSEC concluded that qualifying sales in­
ducements should be amortized over the expected life of 
the contract. In addition, amortization of deferred sales in­
ducements will include an expected lapse assumption that 
is updated each period.
Disclosures
A.60 AcSEC concluded that it is important to provide details of 
the investments of variable separate accounts with guaran­
tees because this provides information on a significant 
asset for many insurance enterprises. In addition, the na­
ture of the guarantee is affected by the nature of the in­
vestments in the separate account. Some respondents to 
the exposure draft recommended that gains and losses on 
assets transferred to a separate account also should be dis­
closed. AcSEC agreed that this would be useful information 
to readers of financial statements, and, therefore, required 
differentiation of gains and losses that were generated from 
the insurance enterprise’s general account investments.
A.61 Several respondents to the exposure draft of the proposed 
SOP suggested that the required disclosures should also in­
clude the significant assumptions used to estimate liabili­
ties for additional insurance benefits and minimum 
guarantees. AcSEC agreed that this information would help
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improve transparency and comparability of financial state­
ments, and concluded that the significant assumptions 
should be required disclosures. AcSEC concluded that the 
detail and amount of the separate account liability bal­
ances subject to various types of guarantees would be use­
ful information to readers of financial statements and 
promote comparability. AcSEC also concluded that it is im­
portant to disclose the net amount at risk by type of guar­
antee because this provides readers of financial statements 
with the maximum amounts the insurance enterprise is at 
risk for guaranteeing.
A.62 AcSEC discussed including sensitivity analysis related to 
significant assumptions used for liability balances related to 
minimum guarantees, and concluded that this information 
would be more appropriate in the management discussion 
and analysis section of an enterprise’s public reporting.
Effective Date and Transition
A.63 AcSEC concluded that this SOP should be initially applied 
at the beginning of the fiscal year that begins after Decem­
ber 15, 2003, which should permit companies sufficient 
time to implement this SOP. AcSEC also concluded that it 
should allow companies the option of early adoption.
A.64 AcSEC concluded that the effect of initially adopting this 
SOP should be reported as a cumulative effect of a change 
in accounting principle (in accordance with the provisions 
of Accounting Principles Board (APB) Opinion No. 20, 
Accounting Changes) and that restatement of prior annual 
financial statements should be prohibited. AcSEC recog­
nizes the benefits of comparable financial statements but 
believes that due to significant judgment and the possible 
use of hindsight in applying this SOP, and the significance 
of the efforts and costs likely to be incurred, retroactive re­
statement or pro forma disclosures in the year of adoption 
should not be required.
A.65 AcSEC considered allowing entities the choice, for certain 
provisions of this SOP, to reclassify previously reported fi­
nancial statements provided there was no valuation basis 
adjustment affecting earnings, while prohibiting reclassifi­
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cation when the valuation provisions of this SOP would af­
fect earnings. AcSEC concluded that the provisions of this 
SOP are not fundamentally different from the FASB State­
ment No. 97 model and that allowing entities the option of 
applying certain provisions and not others would result in 
inconsistent recognition of liabilities, revenue, and acquisi­
tion costs. AcSEC concluded that allowing restatement in 
certain circumstances and not allowing restatement in 
other circumstances is not appropriate. Therefore, AcSEC 
decided not to permit restatement.
A.66 AcSEC concluded that securities subject to FASB State­
ment No. 115 previously carried at fair value that are re­
classified to the general account may be designated as 
held-to-maturity for debt securities, available-for-sale for 
debt and equity securities, or trading for debt and equity 
securities. AcSEC believed that prior to implementation 
of this SOP the assets were being accounted for under 
separate account valuation basis and, after reclassifica­
tion to the general account per the guidance of this SOP, 
they are to be valued under general account guidance. Ac­
cordingly, AcSEC concluded this designation is similar to 
an enterprise initially adopting FASB Statement No. 115 
for those securities. The guidance provided by AcSEC is 
consistent with that provided in FASB Statement No. 115 
for its initial adoption.
A.67 AcSEC also concluded that debt or equity securities sub­
ject to FASB Statement No. 115, previously classified as 
part of a separate account but valued in accordance with 
paragraphs 45 through 51 of FASB Statement No. 60, as 
amended, should maintain the original designation as held- 
to-maturity, available-for-sale, or trading. That designation 
previously was made in accordance with FASB Statement 
No. 115 when the security was purchased and classified as 
a separate account asset. Although under this SOP the se­
curities are now classified as part of the general account, 
the insurance enterprise has already assessed its intent 
under FASB Statement No. 115, which is not changed.
A.68 Any revaluation adjustment for the securities described in 
paragraph A.66 of this SOP should be reported in a man­
ner similar to the cumulative effect of a change in account­
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ing principle through net income or accumulated other 
comprehensive income, as appropriate. In its delibera­
tions, AcSEC considered both the transfer and transition 
guidance provided in FASB Statement No. 115, para­
graphs 15 and 25, related to reclassifications among cate­
gories. AcSEC believes that the transition requirements of 
FASB Statement No. 115 are consistent with AcSEC’s de­
cision not to permit restatement resulting from adoption 
of this SOP.
A.69 AcSEC concluded that, for debt or equity securities subject 
to FASB Statement No. 115 and classified as available-for- 
sale that are part of a contractually referenced pool of as­
sets where a total return will be accrued to the account 
balance liability, and a transition adjustment for the liabil­
ity valuation is reported in accordance with paragraph 
41(e), the related debt or equity securities may be reclassi­
fied to trading upon initial adoption of the SOP. In this 
case, AcSEC believes the combined effect of the asset and 
liability transition adjustments should be reported in a 
manner similar to the cumulative effect of a change in ac­
counting principle. An enterprise may not have designated 
a security as available-for-sale when it purchased the secu­
rity if it had known a contract holder liability designed to 
mimic the return would be recorded based on the refer­
enced asset in the statement of operations. In addition 
AcSEC noted that FASB Statement No. 133, Accounting for  
Derivative Instruments and Hedging Activities, provides 
for similar transition treatment because the guidance for 
hedge accounting significantly changed. AcSEC also made 
the analogy to the transition guidance in EITF Issue No. 
97-14, Accounting for Deferred Compensation Arrange­
ments Where Amounts Earned Are Held in a Rabbi Trust 
and Invested.
A.70 The insurance enterprise’s accounting policies with regard 
to assets other than those subject to FASB Statement No. 
115 should be consistently applied upon reclassification of 
assets from separate accounts to the general account at the 
date of initial adoption of the SOP. AcSEC concluded that 
any revaluation adjustments related to assets other than 
those subject to FASB Statement No. 115 should be re­
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ported in a manner similar to the cumulative effect of a 
change in accounting principle.
A.71 AcSEC concluded that, because this SOP may change the 
way an insurance enterprise applies the mortality and mor­
bidity significance test and that the results of that test may 
change the required liability valuation model, insurance 
enterprises should perform a new determination of signifi­
cance of mortality and morbidity risk resulting from the in­
surance benefit features of the contract for purposes of 
contract classification at the date of initial adoption of this 
SOP. AcSEC considered requiring this determination to be 
made as of original contract issuance, but rejected that ap­
proach because it would not be practicable to obtain and 
document a range of reasonably possible cash flow out­
comes as of those inception dates without the inappropri­
ate use of hindsight. In addition to the burden of 
performing the test without original information, it would 
be difficult to verify the appropriateness of the outcomes. 
AcSEC also considered requiring the determination only 
for new contracts, but was concerned that would cause in­
consistencies in the accounting for similar contracts of an 
enterprise for many years due to the long-duration nature 
of such contracts.
A.72 AcSEC considered whether to require restatement of con­
tract holder liabilities as a result of adoption of this SOP, 
but concluded that restatement is not necessary and may 
not be possible to reconstruct. AcSEC concluded that any 
adjustment to contract holder liabilities from adoption of 
this SOP should be reported in a manner similar to the cu­
mulative effect of a change in accounting principle in ac­
cordance with the provisions of APB Opinion No. 20, 
through net income or, for amounts previously reported 
under EITF Topic No. D-41, accumulated other compre­
hensive income.
A.73 AcSEC, in discussing sales inducements, recognized that 
some insurance enterprises charged those costs to expense 
as incurred. AcSEC believes that the costs of developing 
the information that would be necessary to determine the 
costs that would be capitalized if this SOP were applied 
retroactively would exceed the benefits retroactive applica­
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tion might offer and that such retroactive determination 
should not be made. AcSEC believes this treatment is con­
sistent with transition rules of other accounting guidance, 
such as SOP 98-1, Accounting for the Costs of Computer 
Software Developed or Obtained for Internal Use.
A.74 AcSEC further concluded that the unamortized capitalized 
sales inducement balance at transition should not be ad­
justed, but the balance should be subject to the amortiza­
tion provisions of this SOP on a prospective basis. 
Prospective treatment and prohibition on restating sales 
inducements capitalized is consistent with AcSEC’s con­
clusions on restatement of previously expensed induce­
ments. Identification and amortization of previously 
capitalized costs in accordance with the provisions of this 
SOP should result in an acceptable level of comparability 
and understandability.
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APPENDIX B
Illustration for Presentation of an 
Insurance Enterprise's Interest in a 
Separate Account
B.1 The following example illustrates the presentation in the fi­
nancial statements of an insurance enterprise’s proportion­
ate interest in separate accounts:
An insurance enterprise has a separate account that consists 
of two subaccounts, Subaccount ABC and Subaccount XYZ. 
The insurance enterprise has a 10 percent interest in Subac­
count XYZ, determined based on the fair value of Subac­
count XYZ’s investments. Subaccount XYZ has debt 
securities, mutual fund investments, mortgage loans, and 
real estate. Subaccount XYZ carries its investments at fair 
value; if the general account held these investments, they 
would be accounted for at amortized cost or fair value, de­
pending on the applicable literature. Accounting for equity 
investments, including mutual funds, would depend on per­
centage ownership. If Subaccount XYZ owns more than 50 
percent of the outstanding shares of a mutual fund, the ac­
counting and classification of the items included in the col­
umn titled “Separate Account at General Account Value” 
would reflect consolidating the mutual fund into Subaccount 
XYZ. That is, if the mutual fund held debt and equity securi­
ties, those amounts would be included in the debt and equity 
securities lines of the table below.
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The assets of Subaccount XYZ are composed of the following:
Investment
Separate 
Account at 
Fair Value
Separate 
Account at 
General 
Account 
Value1
Insurer’s
Interest
Proportionate
Interest
Debt securities 400 400 10% 40
Equity securities 300 300 10% 30
Mortgage loans 250 200 10% 20
Real estate 130 100 10% 10
Total assets $1,080 $1,000 10% $100
Balances presented in the insurer’s statement of financial 
condition would reflect:
Assets:
Liabilities:
Debt securities2 
Equity securities2 ,3 
Mortgage loans 
Real estate
Total investments 
Separate account—Assets 
Separate account—Liabilities
40
30
20
10
100
$912
The applicable disclosures for the insurer’s proportionate in­
terest in these specific assets would be included within the 
applicable disclosures for the general account invested assets.
1. Underlying investments valued in a manner similar to any other general 
account asset as prescribed in Financial Accounting Standards Board 
(FASB) Statement of Financial Accounting Standards No. 60, Accounting 
and Reporting by Insurance Enterprises, as amended, paragraphs 45  
through 51.
2. Debt and equity securities need to be designated as either trading or avail­
able-for-sale.
3. If Subaccount XYZ separate account held an investment in a mutual fund, 
a typical situation would be that the insurance enterprise’s investment 
would represent less than a 20 percent ownership and the interest would 
be reported as an FASB Statement No. 115, Accounting for Certain Invest­
ments in Debt and Equity Securities, equity security.
4. Separate account assets at fair value of $ 1,080 x 90% (contract holders’ 
proportionate interest).
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$ 9724
The XYZ separate account’s balances for net investment in­
come and gains and losses:
XYZ
Separate General
Account Insurer’s Apportioned Account
Total Interest Values Classification
Net investment 
income (N II)
65 10% 6.5 Revenue
Realized gains 
and losses
20 10% 2.0 Revenue
Unrealized gains and losses:
Debt securities 8 10% 0.8 Revenue 
or O C I5
Equity securities 25 10% 2.5 Revenue 
or O C I5
Mortgage loans 5 10% 0.5 Not
recognized6
Real estate 2 10% 0.2 Not
recognized6
Total N II 
and gains 
and losses $125 12.5
Assume in the second year:
• Insurer interest is lowered to 5 percent on the last 
day of the first quarter.
• At the time of dilution:
-  Separate account at fair value was $ 1,090.
-  Separate account at general account value was $ 1,007.
• Fair value of each investment increases 1 percent.
5. Unrealized gains should be included in revenue or other comprehensive in­
come (OCI) depending on security classification as trading or available-for- 
sale. Unrealized losses result in other than temporary impairments, as noted 
in paragraph 14(a) of this SOP, and should be recognized immediately.
6. Unrealized gains are not recognized. Cumulative unrealized losses may 
result in recognition of an other-than-temporary impairment.
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End of first quarter:
Separate
Account at Proportionate
Separate General Interest
Account at Account Insurer’s After
Investment Fair Value Value Interest Dilution
Debt securities 404 404 5% 20
Equity securities 303 303 5% 15
Mortgage loans 252 200 5% 10
Real estate 131 100 5% __________5
Total assets $1,090 $1,007 50
Balances presented in the insurer’s statement of financial 
condition would reflect:
Assets: Debt securities 20
Equity securities 15
Mortgage loans 10
Real estate 5
Total investments 50
Separate account—Assets $1,0367
The XYZ separate account’s balances for net investment in­
come and gains and losses for the quarter:
XYZ
Separate
Account Insurer’s Apportioned 
Total Interest Values
Net investment income 16.3 10% 1.6
Unrealized gains and losses:
Debt securities 4.0 10% 0.4
Equity securities 3.0 10% 0.3
Mortgage loans 2.5 10% 0.3
Real estate 1.2 10% 0.1
Total NII and
gains and losses #27 2.7
7. $ 1,090 x 95%
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The seed money change for the quarter would be accounted 
for as follows:
Amount due to proportionate interest in revenue 2.3
Gain recognition on dilution of interest 4.28
8. Fair value of separate account less general account value of separate ac­
count multiplied by dilution, ($1,090-$1,007) x 5%. This is the gain on 
mortgage loans and real estate, assuming debt and equity securities have 
been classified as trading. If debt and equity securities had been classified 
as available for sale, the gain or loss on dilution would also be calculated 
using amortized cost of debt and equity securities.
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APPENDIX C
Sample Disclosures
C.1 This appendix provides an illustration of the financial 
statement disclosure requirements relating to paragraph 
38 of this Statement of Position (SOP). Entities are not re­
quired to display the disclosure information contained 
herein in the specific manner illustrated. Alternative ways 
of disclosing the information are permissible provided that 
the disclosure requirements of this SOP, as described in 
paragraph 38, are met, such as showing account balances 
of contracts with guarantees by type of benefit.
The company issues variable contracts through its separate 
accounts for which investment income and investment gains 
and losses accrue directly to, and investment risk is borne 
by, the contract holder (traditional variable annuities). The 
company also issues variable annuity and life contracts 
through separate accounts where the company contractually 
guarantees to the contract holder (variable contracts with 
guarantees) either (a ) return of no less than total deposits 
made to the contract less any partial withdrawals, (b ) total 
deposits made to the contract less any partial withdrawals 
plus a minimum return, or (c ) the highest contract value on 
a specified anniversary date minus any withdrawals following 
the contract anniversary. These guarantees include benefits 
that are payable in the event of death, annuitization, or at 
specified dates during the accumulation period. During 20X1 
and 20X2 there were no gains or losses on transfers of assets 
from the general account to the separate account.
The assets supporting the variable portion of both tradi­
tional variable annuities and variable contracts with guaran­
tees are carried at fair value and reported as summary total 
separate account assets with an equivalent summary total 
reported for liabilities. Amounts assessed against the con­
tract holders for mortality, administrative, and other ser­
vices are included in revenue and changes in liabilities for 
minimum guarantees are included in policyholder benefits 
in the Statement of Operations. Separate account net in-
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vestment income, net investment gains and losses, and the 
related liability changes are offset within the same line item 
in the Statement of Operations.
At December 31, 20X1 and 20X2, the company had the fol­
lowing variable contracts with guarantees. (Note that the 
company’s variable contracts with guarantees may offer 
more than one type of guarantee in each contract; therefore, 
the amounts listed are not mutually exclusive.) For guaran­
tees of amounts in the event of death, the net amount at risk 
is defined as the current guaranteed minimum death benefit 
in excess of the current account balance at the balance sheet 
date. For guarantees of amounts at annuitization, the net 
amount at risk is defined as the present value of the mini­
mum guaranteed annuity payments available to the contract 
holder determined in accordance with the terms of the con­
tract in excess of the current account balance. For guaran­
tees of accumulation balances, the net amount at risk is 
defined as the guaranteed minimum accumulation balance 
minus the current account balance.
December 31
20X1 20X2
Return of net deposits
In the event of death
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Average attained age of contract holders XX XX
At annuitization
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Weighted average period remaining
until expected annuitization XX XX
Accumulation at specified date
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Return of net deposits plus a minimum return
In the event of death
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Average attained age of contract holders XX XX
Range of guaranteed minimum return rates x—x% X—X%
At annuitization
Account value $xxx $xxx
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Net amount at risk $xxx $xxx
Weighted average period remaining
until expected annuitization XX XX
Range of guaranteed minimum return rates x—x% x—x %
Accumulation at specified date
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Range of guaranteed minimum return rates x—x% x—x%
Highest specified anniversary account value minus withdrawals
post anniversary
In the event of death
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Average attained age of contract holders XX XX
At annuitization
Account value $xxx $xxx
Net amount at risk $xxx $xxx
Weighted average period remaining
until expected annuitization XX XX
Accumulation at specified date
Account value $xxx $ XXX
Net amount at risk $xxx $xxx
Account balances of contracts with guarantees were invested in 
variable separate accounts as follows:
Asset Type December 31, 20X1 December 31, 20X2
U.S. Treasury securities 
and obligations of U.S. 
government corporations
and agencies $ $
Obligations of states of 
the United States and 
political subdivisions of 
the states
Corporate debt securities:
—Investment grade 
—Noninvestment grade 
Foreign debt securities 
Mortgage-backed securities
6 5
Equity securities (including mutual funds)1 
Real estate 
Mortgage loans
Derivative financial instruments
Gash and cash equivalents _______
Total $X,XXX,XXX $X,XXX,XXX
The following summarizes the liabilities for guarantees on 
variable contracts reflected in the general account:
Minimum Guaranteed Guaranteed
Guaranteed Minimum Minimum
Death Accumulation Income
Benefit Benefit Benefit
(MGDB) (GMAB) (GMIB) Totals
Balance at
January 1 $X,XXX,XXX $X,XXX,XXX $ X,XXX,XXX $X,XXX,XXX
Incurred
guarantee
benefits2 X,XXX,XXX X,XXX,XXX X,XXX,XXX $X,XXX,XXX
Paid guarantee
benefits X,XXX,XXX X,XXX,XXX X,XXX,XXX $X,XXX,XXX
Balance at 
December 31,
20X2 $X,XXX,XXX $X,XXX,XXX $X,XXX,XXX $X,XXX,XXX
The MGDB liability is determined each period end by esti­
mating the expected value of death benefits in excess of the 
projected account balance and recognizing the excess rat­
ably over the accumulation period based on total expected 
assessments. The Company regularly evaluates estimates 
used and adjusts the additional liability balance, with a re­
lated charge or credit to benefit expense, if actual experi­
ence or other evidence suggests that earlier assumptions 
should be revised. [Include discussion of change in esti­
mate if material. ]
1. The insurance enterprise may want to consider disclosing mutual funds 
by investment objective or other meaningful groupings that are useful in 
understanding the nature of the guarantee risk.
2. For guaranteed minimum accumulation benefits, incurred guarantee ben­
efits incorporates all changes in fair value other than amounts resulting 
from paid guarantee benefits.
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The following assumptions and methodology were used to 
determine the MGDB liability at December 31, 20X2:
• Data used was 1,000 stochastically generated invest­
ment performance scenarios.
• Mean investment performance assumption was XX.
• Volatility assumption was XX.
• Mortality was assumed to be 90 percent of the Annu­
ity 2000 table.
• Lapse rates vary by contract type and duration and 
range from 1 percent to 20 percent, with an average 
of 3 percent.
• Discount rate was XX%.
Guaranteed minimum accumulation benefits are considered 
to be derivatives under Financial Accounting Standards 
Board Statement of Financial Accounting Standards No. 133, 
Accounting for Derivative Instruments and Hedging Activi­
ties, and are recognized at fair value through earnings.
The guaranteed minimum income benefit (GMIB) liability is 
determined each period end by estimating the expected 
value of the annuitization benefits in excess of the projected 
account balance at the date of annuitization and recognizing 
the excess ratably over the accumulation period based on 
total expected assessments. The Company regularly evalu­
ates estimates used and adjusts the additional liability bal­
ance, with a related charge or credit to benefit expense, if 
actual experience or other evidence suggests that earlier as­
sumptions should be revised. [Include discussion of change 
in estimate if material.] The assumptions used for calculat­
ing the GMIB liability at December 31, 20X2, are consistent 
with those used for calculating the MGDB liability. In addi­
tion, the calculation of the GMIB liability assumes X percent 
of the potential annuitizations that would be beneficial to the 
contract holder will be elected.
67
A PPENDIX D_________________  
Application of Statement of 
Position— Product and Product 
Feature Examples
M arket Value Annuity
D.1 A market value annuity (MVA) provides for a return of prin­
cipal plus a fixed rate of return if held to maturity (referred 
to herein as book value), or, alternatively, a “market ad­
justed value” if surrendered prior to maturity. The product 
is also sometimes referred to as a “market value adjusted 
annuity” or “modified guaranteed annuity.” The product 
typically provides for a single premium that may be in­
vested for a specified term, with typical terms of 1 to 10 
years. A fixed interest rate is specified in the contract based 
upon the term selected. The contract contains surrender 
values that are based upon a market value adjustment for­
mula if held for shorter periods. The formula typically is 
based on current crediting rates being offered for new MVA 
purchases with terms equal to the remaining term to matu­
rity. The market value adjustment may be positive or nega­
tive, depending on crediting rates at surrender.
D.2 Because the insurance enterprise provides a fixed return for 
a specified period, market value adjusted annuities written 
through a separate account do not meet the criteria in para­
graph 11(d) of this Statement of Position (SOP). Under 
paragraph 11(d) of this SOP, all investment performance, 
net of contract fees, must be required to be passed through 
to the contract holder to qualify for separate account treat­
ment. Therefore, the assets and liabilities related to market 
value adjusted annuities should be accounted for and re­
ported as general account assets and liabilities.
D.3 Under the model, described in paragraphs 20 through 23 of 
this SOP, the liability to be held for market value adjusted
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annuities is the accrued account balance using the con­
tractually specified rate. The market value adjusted 
amount generally is available at surrender only and is not 
available at contract maturity; therefore, the market value 
adjustment is considered a surrender charge or credit.
Tw o-Tier Annuity
D.4 A two-tier annuity has two crediting rates applied to funds 
deposited into the contract. One rate is used to calculate the 
account balance if the contract holder elects to surrender 
the contract for cash, and is referred to as the “lower tier.” A 
second rate, typically higher, is used to calculate the ac­
count balance, but only if the contract holder elects to an­
nuitize the contract, and is referred to as the “upper tier.”
D.5 This SOP requires that the accrued account balance during 
the accumulation phase be calculated using the lower-tier 
rate because the account balance accumulated at the lower 
tier is the amount that would be available in cash at matu­
rity if the contract holder elects not to annuitize the con­
tract. An additional liability determined in accordance 
with paragraphs 31 through 33 of this SOP should be rec­
ognized during the accumulation phase for the annuitiza­
tion benefit in excess of the accrued account balance. 
When there is an additional liability for the annuitization 
benefit and a contract holder elects to annuitize, the pre­
sent value of annuitization payments, including related in­
cremental claims adjustment expenses, discounted at 
expected investment yields would represent the single pre­
mium used to “purchase” the annuitization benefit.
Variable Annuity W ith Guaranteed 
Minimum Accumulation Benefit
D.6 Some deferred annuities provide a minimum accumulation 
benefit or a guaranteed account value floor that is available 
to the contract holder in cash. These benefits are often re­
ferred to as guaranteed minimum accumulation benefits, 
or GMABs.
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D.7 Example: Contract holder deposits $100,000 in a deferred 
variable annuity that provides for a GMAB that guarantees 
that at a specified anniversary date (for example, five 
years), the contract holder’s account balance will be the 
greater of (a) the account value, as determined by the sep­
arate account assets, or (b) deposits less partial with­
drawals accumulated at 3 percent interest compounded 
annually. At the specified anniversary date the contract 
holder’s account balance has declined to $80,000 due to 
stock market declines. The guaranteed minimum value of 
the $100,000 deposit compounded annually at 3 percent 
interest is $115,930. The contract holder’s account balance 
will be increased to the greater amount, resulting in an ac­
count balance of $115,930. Financial Accounting Stan­
dards Board (FASB) Derivative Implementation Issue B8, 
Identification of the Host Contract in a Nontraditional 
Variable Annuity Contract, specifies that a GMAB is an 
embedded derivative subject to the requirements of FASB 
Statement No. 133, Accounting for Derivative Instru­
ments and Hedging Activities. The remaining part of the 
hybrid contract should be accounted for separately.
Variable Annuity W ith Guaranteed 
Minimum Income Benefit
D.8 Some deferred variable annuities guarantee that, regard­
less of separate account investment performance, the con­
tract holder will be able to annuitize after a specified date 
and receive a defined minimum periodic benefit. These 
benefits are available only if the contract holder elects to 
annuitize and are often referred to as guaranteed minimum 
income benefits, or GMIBs.
D.9 Example: A contract holder deposits $100,000 in a deferred 
variable annuity that provides a GMIB. The GMIB contract 
specifies that if the contract holder elects to annuitize, the 
amount available to annuitize will be the higher of the then 
account balance or the sum of deposits less withdrawals. 
The contract holder directs the deposit to equity-based 
funds within the separate account. At the date that the con­
tract holder chooses to annuitize, the account balance has 
declined to $80,000 due to stock market declines. The con­
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tract holder elects a 20-year period-certain fixed payout an­
nuity, payable monthly in arrears. Using the $100,000 guar­
anteed minimum account value at the date of annuitization 
and a guaranteed 3 percent crediting rate, the fixed 
monthly periodic annuity payment is $554.
D.10 During the accumulation phase, if the GMIB feature is not 
accounted for under the provisions of FASB Statement No. 
133, an additional liability should be established if the pre­
sent value of expected annuitization payments at the annu­
itization date exceeds the expected account balance at the 
expected annuitization date. That additional liability 
should be determined in accordance with paragraphs 31 
through 33 of this SOP. When there is an additional liability 
for the annuitization benefit and a contract holder elects to 
annuitize, the present value of annuitization payments, in­
cluding related claims adjustment expenses, discounted at 
expected investment yields would represent the single pre­
mium used to “purchase” the annuitization benefit.
D.11 FASB Derivative Implementation Issue B25, Deferred Vari­
able Annuity Contracts with Payment Alternatives at the 
End of the Accumulation Period, specifies that a GMIB does 
not meet the definition of an embedded derivative if it can­
not be net settled. If the GMIB can be net settled, the guar­
antee is an embedded derivative in the accumulation period 
and should be accounted for under FASB Statement No. 133.
Variable Annuity and Life Insurance
D.12 Variable annuity and variable life insurance contracts pro­
vide the contract holder with a number of investment al­
ternatives. Many of those investment alternatives will be 
separate account funds, such as equity, aggressive equity, 
high-grade corporate bond, mortgage loan, real estate and 
similar funds, that satisfy the criteria contained in para­
graph 11 of this SOP. Other investment alternatives could 
include guaranteed investment and market value adjusted 
separate accounts as well as a general account fixed inter­
est rate option.
D.13 Example: The contract holder deposits $100,000 in a de­
ferred variable annuity that has no front-end load. The
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contract holder directs the allocation of the deposit to 
the following: aggressive growth equity fund, $25,000; 
high-yield corporate bond fund, $25,000; five-year guar­
anteed interest separate account, $25,000; and general 
account, $25,000.
D.14 Assets representing the contract holder’s funds in the ag­
gressive growth equity fund and high-yield corporate bond 
fund separate accounts satisfy all the criteria of paragraph 
11 of this Statement of Position (SOP). The allocation to 
the guaranteed interest separate account does not satisfy 
the criterion in paragraph 11(d) of this SOP. Therefore, as­
sets representing the contract holder’s funds in the guaran­
teed interest separate account will be presented in the 
insurance enterprise’s financial statements integrated with 
general account assets and liabilities. This reporting is ap­
propriate even in those instances where the separate ac­
count arrangements with those contracts have been 
approved by regulatory authorities as separate account 
contracts. These contracts are often referred to as spread 
products, where the insurer bears the investment risk and 
its profits are derived primarily from the excess of invest­
ment performance over net amounts credited to the con­
tract holder. Amounts related to this contract that are 
directed to the general account option will, of course, be 
shown within general account balances.
Group Participating Pension Contracts
D.15 Some FASB Statement No. 97, Accounting and Reporting 
by Insurance Enterprises for Certain Long-Duration Con­
tracts and for Realized Gains and Losses from the Sale of 
Investments, contracts between insurance enterprises and 
pension plans have account balance crediting provisions 
that give the contract holder the total return based on a 
referenced pool of assets over the life of the contract either 
through crediting rates or termination adjustments. The 
ongoing crediting to the account balance may be based on 
statutory, cash basis, or book value returns. The contracts 
may not have a maturity date but specify that upon surren­
der any remaining return on the referenced pool of assets 
on the termination date not yet credited will be a termina-
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tion adjustment. The referenced pool of assets may include 
mortgage loans, real estate, and equity and debt securities.
D.16 This SOP requires that, for contracts not accounted for 
under the provisions of FASB Statement No. 133, the liabil­
ity for the contract holder account balance be based on the 
fair value of the referenced pool of assets without regard to 
the accounting under generally accepted accounting prin­
ciples for the assets in the referenced pool of assets, with 
any change in the liability recognized through earnings.
Sales Inducements to Contract Holders
D.17 Sales inducements to contract holders typically can be 
characterized as one of the following types: immediate 
bonuses, persistency bonuses, and enhanced crediting 
rate bonuses.
D.18 In the case of the immediate bonus, the insurance com­
pany is obligated to credit to the contract holder’s account 
the sales inducement as a result of signing the contract. 
The contract holder account balance is increased for the 
full amount of the immediate bonus on the date that the 
bonus is contractually granted. If the criteria in paragraph 
37 of this SOP are met, an asset should be established for 
the same amount. Even if a company were to impose a pre­
payment penalty designed to recover the sales induce­
ment, paragraph 18 of FASB Statement No. 97 specifies 
that amounts assessed against policyholders in future peri­
ods cannot be considered in determining the liability for 
policy benefits. The prepayment penalty for the sales in­
ducement would be treated no differently than any other 
surrender charge.
D.19 A persistency bonus is credited to the contract holder ac­
count balance at the end of a specified period if the con­
tract remains in force at that date. The amount that will be 
credited in accordance with the terms of the contract 
should be accrued as a component of the contract holder 
account balance ratably over the vesting period. If the cri­
teria in paragraph 37 of this SOP are met, an asset should 
be established. While it may not become payable by the in­
surance company until some future vesting or crediting
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date, the insurance enterprise is prohibited by FASB State­
ment No. 97 from anticipating surrenders and must assume 
the contract holder will persist to earn the bonus.
D.20 In an enhanced crediting rate sales inducement, the insur­
ance enterprise offers customers a crediting rate for a 
stated period in excess of that currently being offered by 
the company for other similar contracts. Pursuant to the 
contract, the enhanced crediting rate is applicable for a 
limited period of time, after which, the rate is “reset” 
under the contractual provisions, typically at the discre­
tion of the insurance enterprise. The liability for an en­
hanced crediting rate sales inducement should be accrued 
ratably over the bonus crediting period. If the criteria in 
paragraph 37 of this SOP are met, an asset should be estab­
lished for the same amount.
Variable Annuity W ith Long-Term 
Care Benefit
D.21 Some deferred annuities provide that if during the accumu­
lation phase, the contract holder has an insurable event 
(for example, disability, loss of “activities of daily living”) 
that meets the criteria specified in the contract, additional 
benefits in excess of the account balance will be available. 
This feature should be evaluated and accounted for in ac­
cordance with paragraphs 24 through 30 of this SOP.
Annuities W ith Earnings 
Protection Benefit
D.22 Some annuities provide that in the event of death, the ben­
eficiary will receive a benefit in addition to the account 
balance equal to a percentage (for example, 40 percent) of 
the difference between the account balance and the de­
posits less withdrawals. This feature is a death benefit and 
should be evaluated and accounted for in accordance with 
paragraphs 24 through 30 of this SOP.
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APPENDIX E_________________  
Illustrations of the Calculation 
of Minimum Guaranteed 
Death Benefit Liability
E.1 The accompanying schedules illustrate how to calculate an 
additional liability for a portfolio of variable annuity con­
tracts with a minimum guaranteed death benefit (MGDB) 
feature as noted in paragraphs 24 through 29 of this State­
ment of Position (SOP). For this illustration it is assumed 
that the guidance in paragraphs 24 and 25 of this SOP has 
been followed, with the conclusion that the mortality and 
morbidity risk associated with insurance benefit features is 
other than nominal.
E.2 The following is assumed for contracts in this illustration:
a. Variable annuity contracts have no front-end loads.
b. Mortality assessments include any explicit assess­
ments for enhanced death benefit feature.
c. Surrender charges are calculated based on a percent­
age of premiums.
d. Expense assessments are a fixed annual charge.
e. Discount rate of 8 percent is the same rate as used 
for deferred acquisition cost amortization.
E.3 Schedules 6 through 10 contain the same basic assump­
tions as Schedule 1, but with the impact on the adjusted 
gross profits of a 10 percent increase in account balances 
(not shown in schedules) in year 2.
E.4 The illustrations display the computations involved in:
a. Gross profits
b. Benefit ratio
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c. Additional MGDB liability
d. Adjusted gross profits that should be used for the 
amortization of deferred acquisition costs1
Note: Columns in schedules do not cross foot due to rounding.
1. The estimated gross profits used for the amortization of deferred acquisition costs 
should be adjusted to reflect the incidence of assessments and loss expense as a result 
of the recognition of the liability; refer to paragraph 29 of this Statement of Position.
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Schedule 2— Computation of Benefit Ratio
Present value of excess death benefits paid 724.88
Divided by present value of total revenue 12,304.07
Equals benefit ratio 5.8914%
Schedule 3— Computation of Year 1 Additional MGDB Liability
Cumulative revenue recognized 
Multiplied by benefit ratio 
Equals year 1 additional liability
868.00 
5.8914% 
($) 51.14
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Schedule 5— Estimated Gross Profits to Use for Amortization of
Deferred Acquisition Costs
Year
Unadjusted 
Gross Profits -
Change in 
Additional 
Liability =
Estimated 
Gross Profits
1 843.00 51.14 791.86
2 763.55 47.63 715.92
3 811.80 46.81 765.00
4 855.22 48.57 806.64
5 900.54 50.45 850.09
6 961.38 46.82 914.56
7 966.82 46.28 920.55
8 838.07 40.66 797.40
9 996.05 40.70 955.35
10 1,038.61 36.86 1,001.75
11 1,063.08 25.75 1,037.34
12 1,110.44 19.72 1,090.72
13 1,122.78 8.54 1,114.24
14 1,143.86 -9.27 1,153.13
15 1,184.28 -15.66 1,199.94
16 1,235.39 -15.55 1,250.95
17 1,202.54 -72.39 1,274.93
18 1,203.27 -102.14 1,305.41
19 1,192.05 -142.75 1,334.80
20 1,222.52 -152.16 1,374.68
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Schedule 7—Computation of Benefit Ratio at Year 2
Present value of excess death 
benefits paid
759.24
Divided by present 
value of total revenue = 13,326.45
Equals benefit ratio 5.6972%
Schedule 8—Computation of Year 2 Additional MGDB Liability
Cumulative revenue recognized
Year 1 868.00
Year 2 1026.58
Total 1,894.58
Multiplied by benefit ratio 5.6972%
Equals year 2 
additional liability1 ($) 107.94
1. Excludes interest and any deduction for actual claim expenses.
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Schedule 10—Estimated Gross Profits to Use for Amortization of
Deferred Acquisition Costs
Change in
Year
Unadjusted 
Gross Profits -
Additional 
Liability =
Estimated 
Gross Profits
1 843.00 51.14 791.86
2 842.88 60.75 782.13
3 888.98 56.68 832.30
4 933.50 56.14 877.36
5 982.63 57.38 925.25
6 1,046.10 52.70 993.40
7 1,055.15 52.01 1,003.14
8 919.23 46.04 873.19
9 1,093.67 46.90 1,046.77
10 1,136.32 40.67 1,095.65
11 1,162.64 27.83 1,134.81
12 1,216.83 21.97 1,194.86
13 1,228.64 8.65 1,219.99
14 1,251.00 -11.31 1,262.31
15 1,297.12 -16.71 1,313.83
16 1,348.33 -19.02 1,367.35
17 1,309.42 -83.41 1,392.83
18 1,307.43 -117.50 1,424.93
19 1,297.44 -160.45 1,457.89
20 1,332.00 -170.46 1,502.46
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GLOSSARY
accumulation phase. The period during an annuity contract prior to an­
nuitization. An insurance enterprise may refer to this type of annuity as 
a deferred annuity.
annuitization phase. The period during which the contract holder is re­
ceiving periodic payments from an annuity, also referred to as the pay­
out phase.
general account. All operations of an insurance enterprise that are not 
reported in the separate account(s).
guaranteed investment option. Component of a variable contract that 
guarantees a specific rate of performance.
guaranteed minimum income benefit (GMIB). Benefit normally offered 
with deferred variable annuities to provide a guaranteed minimum 
amount available for annuitization after a specified period in addition to 
a guaranteed minimum annuity rate. That is, the fixed periodic annuity 
payments would be determined using the higher of the current accumu­
lated account value that exists at the date of annuitization or the guar­
anteed amount.
long-term care (LTC) benefit. Benefit offered in an annuity product 
with a rider providing amounts in excess of the account balance to pro­
vide for LTC benefits if contract holder meets the criteria for restric­
tions on activities of daily living.
minimum guaranteed death benefit (MGDB). A feature in an annuity, 
life insurance, or similar contract that provides that in the event of an 
insured’s death, the beneficiary (or insurer in the case of a reinsurance 
contract) will receive the higher of the current account balance of the 
contract or another amount defined in the contract.
morbidity. The relative incidence of disability due to disease or physical 
impairment.
mortality. The relative incidence of death in a given time or place.
net amount at risk. The guaranteed benefit in excess of the current ac­
count balance. For guarantees in the event of death, the net amount at risk 
is the minimum guaranteed amount available to the contract holder upon 
death in excess of the contract holder’s account balance at the balance 
sheet date. For guarantees of amounts at annuitization, the net amount at 
risk is defined as the present value of the minimum guaranteed annuity 
payments available to the contract holder determined in accordance with 
the terms of the contract in excess of the current account balance.
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sales inducements. Sales inducements are product features that en­
hance the investment yield to the contract holder on the contract. The 
three main types of sales inducements are (1) day-one bonus, which in­
creases the account value at inception, also called immediate bonus; (2) 
persistency bonus, which increases the account value at the end of a 
specified period; and (3) enhanced yield, which credits interest for a 
specified period in excess of rates currently being offered for other sim­
ilar contracts.
seed money. An investment of non-contract holder funds by an insurer 
in a separate account when it is established, to support the initial or on­
going operations of the separate account.
separate account. A separate investment account established and main­
tained by an insurance enterprise under relevant state insurance law to 
which funds have been allocated for certain contracts of the insurance 
enterprise or similar accounts used for foreign originated products. Often 
for administrative purposes, separate account subaccounts with differing 
investment objectives are created within a single separate account.
separate account arrangement. An arrangement under which all or a 
portion of a contract holder’s funds is allocated to a specific separate ac­
count maintained by the insurance enterprise. Examples include a vari­
able life insurance contract offered through an insurance enterprise’s 
high return separate account and a contract holder’s allocation of a por­
tion of his or her deposit in a deferred variable annuity to a growth eq­
uity fund.
traditional variable annuity. An insurance product in which all the con­
tract holder’s payments are used to purchase units of a separate ac­
count. The contract holder directs the allocation of the account value 
among various investment alternatives and bears the investment risk. 
The units may be surrendered for their current value in cash (usually 
less a surrender change) or applied to purchase annuity income. The in­
surance enterprise periodically deducts mortality and expense charges 
from the account.
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